https://www.pharmaceutical-business-review.com/news/humana-pfizer-in-health-care-research-collaboration-agreement-141011/ 2011-10-14T06:17:00+00:00 https://www.pharmaceutical-business-review.com/news/noven-registers-lawsuit-in-us-district-court-against-watson-141011/ 2011-10-14T07:14:00+00:00 https://www.pharmaceutical-business-review.com/news/kissei-funds-for-medicinova-asthma-drug-development-141011/ 2011-10-14T07:18:00+00:00 https://www.pharmaceutical-business-review.com/news/inovacia-develops-schistosomiasis-treatment-141011/ 2011-10-14T07:36:00+00:00 https://www.pharmaceutical-business-review.com/news/merge-radiology-information-software-wins-complete-ehr-certification-171011/ 2011-10-17T00:49:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-acquires-cephalon-171011/ 2011-10-17T00:52:00+00:00 https://www.pharmaceutical-business-review.com/news/beigene-janssen-strike-deal-to-co-develop-in-license-oncology-compounds-171011/ 2011-10-17T00:59:00+00:00 https://www.pharmaceutical-business-review.com/news/insmed-receives-fda-notification-over-arikace-in-ntm-treatment-171011/ 2011-10-17T01:04:00+00:00 https://www.pharmaceutical-business-review.com/news/beijing-jingxinlong-adopts-efuture-logistics-management-solutions-171011/ 2011-10-17T01:06:00+00:00 https://www.pharmaceutical-business-review.com/news/biodesix-presents-efficacy-results-of-veristrat-in-rcc-patients-171011/ 2011-10-17T03:11:00+00:00 https://www.pharmaceutical-business-review.com/news/app-pharmaceuticals-increases-propofol-production-171011/ 2011-10-17T03:19:00+00:00 https://www.pharmaceutical-business-review.com/news/lannett-introduces-fda-approved-drugs-171011/ 2011-10-17T03:22:00+00:00 https://www.pharmaceutical-business-review.com/news/dnaa-to-distribute-nutra-pharma-nyloxin-in-panama-171011/ 2011-10-17T03:24:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-to-acquire-anadys-171011/ 2011-10-17T03:28:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-gifts-27m-worth-medicines-to-libya-171011/ 2011-10-17T05:53:00+00:00 https://www.pharmaceutical-business-review.com/news/genzyme-expands-waterford-facility-171011/ 2011-10-17T06:47:00+00:00 https://www.pharmaceutical-business-review.com/news/paksense-unveils-temperature-monitoring-label-171011/ 2011-10-17T06:50:00+00:00 https://www.pharmaceutical-business-review.com/news/icf-wins-new-contract-to-support-ctg-program-171011/ 2011-10-17T07:20:00+00:00 https://www.pharmaceutical-business-review.com/news/ferriprox-receives-fda-approval-to-treat-iron-overload-171011/ 2011-10-17T07:51:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-johns-hopkins-in-neurological-drug-discovery-research-collaboration-171011/ 2011-10-17T07:54:00+00:00 https://www.pharmaceutical-business-review.com/news/wuxi-acquires-abgent-171011/ 2011-10-17T07:57:00+00:00 https://www.pharmaceutical-business-review.com/news/biosilta-introduces-enpresso-yeast-defined-tablet-171011/ 2011-10-17T08:07:00+00:00 https://www.pharmaceutical-business-review.com/news/thermo-fisher-unveils-revco-ult-freezers-181011/ 2011-10-17T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/oracle-unveils-new-web-based-data-collection-system-181011/ 2011-10-17T21:21:00+00:00 https://www.pharmaceutical-business-review.com/news/gprd-druglogic-enter-data-license-agreement-181011/ 2011-10-17T22:20:00+00:00 https://www.pharmaceutical-business-review.com/news/watson-files-anda-for-atelvia-with-fda-181011/ 2011-10-18T00:38:00+00:00 https://www.pharmaceutical-business-review.com/news/chemocentryx-commences-ccx168-phase-ii-trial-to-treat-vasculitis-181011/ 2011-10-18T00:47:00+00:00 https://www.pharmaceutical-business-review.com/news/rusnano-nearmedic-plus-to-set-up-pharmaceutical-manufacturing-facility-181011/ 2011-10-18T00:51:00+00:00 https://www.pharmaceutical-business-review.com/news/tpp-university-of-dundee-to-set-up-drug-development-fund-181011/ 2011-10-18T02:58:00+00:00 https://www.pharmaceutical-business-review.com/news/bccrc-reports-efficacy-results-of-her2-breast-cancer-treatment-to-bioasis-181011/ 2011-10-18T03:47:00+00:00 https://www.pharmaceutical-business-review.com/news/athersys-completes-patient-enrollment-for-phase-i-study-of-multistem-181011/ 2011-10-18T03:54:00+00:00 https://www.pharmaceutical-business-review.com/news/archimedes-introduces-lazanda-nasal-spray-in-us-181011/ 2011-10-18T05:32:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-oxford-biomedica-ushstat-for-usher-syndrome-181011/ 2011-10-18T05:38:00+00:00 https://www.pharmaceutical-business-review.com/news/panmira-appoints-hari-kumar-as-new-ceo-181011/ 2011-10-18T05:45:00+00:00 https://www.pharmaceutical-business-review.com/news/norgine-jubilant-in-git-drug-discovery-collaboration-181011/ 2011-10-18T07:52:00+00:00 https://www.pharmaceutical-business-review.com/news/honeywell-introduces-protective-film-for-pharma-packaging-181011/ 2011-10-18T07:55:00+00:00 https://www.pharmaceutical-business-review.com/news/ab-science-begins-patient-enrollment-for-masitinib-trial-in-multiple-myeloma-181011/ 2011-10-18T08:00:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-subcutaneous-herceptin-phase-3-trial-yields-positive-data-181011/ 2011-10-18T08:04:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-oxford-ushstat-ind-application-181011/ 2011-10-18T08:11:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-methylgene-antifungal-drug-ind-application-181011/ 2011-10-18T08:19:00+00:00 https://www.pharmaceutical-business-review.com/news/veeva-introduces-promotional-materials-management-solution-191011/ 2011-10-18T19:39:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-forest-laboratories-to-commence-ceftazidime-trial-for-bacterial-infections-191011/ 2011-10-19T01:00:00+00:00 https://www.pharmaceutical-business-review.com/news/somalogic-novartis-ink-drug-discovery-and-development-deal-191011/ 2011-10-19T01:03:00+00:00 https://www.pharmaceutical-business-review.com/news/schneck-chooses-omnicell-medication-management-solutions-191011/ 2011-10-19T02:27:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-begins-phase-3-trial-for-tak-875-in-type-2-diabetes-patients-191011/ 2011-10-19T02:48:00+00:00 https://www.pharmaceutical-business-review.com/news/angel-biotechnology-materia-medica-to-enter-jv-191011/ 2011-10-19T02:53:00+00:00 https://www.pharmaceutical-business-review.com/news/servier-miragen-enter-352m-deal-for-research-and-drug-development-191011/ 2011-10-19T02:58:00+00:00 https://www.pharmaceutical-business-review.com/news/ampio-demonstrates-impact-of-danazol-in-allergic-rhinitis-treatment-191011/ 2011-10-19T05:09:00+00:00 https://www.pharmaceutical-business-review.com/news/perrigo-files-nda-for-generic-version-of-patanase-nasal-spray-191011/ 2011-10-19T05:11:00+00:00 https://www.pharmaceutical-business-review.com/news/coorga-nutraceuticals-launches-new-pill-for-gray-hair-treatment-191011/ 2011-10-19T06:27:00+00:00 https://www.pharmaceutical-business-review.com/news/true-healthy-adds-vitamin-supplements-to-product-line-191011/ 2011-10-19T06:36:00+00:00 https://www.pharmaceutical-business-review.com/news/flamel-gsk-sign-multi-year-supply-agreement-191011/ 2011-10-19T06:42:00+00:00 https://www.pharmaceutical-business-review.com/news/par-pharma-gains-rights-to-teva-pharma-products-191011/ 2011-10-19T07:08:00+00:00 https://www.pharmaceutical-business-review.com/news/amerigen-stason-in-generic-oral-oncology-products-development-agreement-191011/ 2011-10-19T07:18:00+00:00 https://www.pharmaceutical-business-review.com/news/natco-inks-deal-with-mabxience-to-manufacture-mab-drugs-191011/ 2011-10-19T07:48:00+00:00 https://www.pharmaceutical-business-review.com/news/hikma-pharmaceuticals-opens-new-manufacturing-company-191011/ 2011-10-19T07:53:00+00:00 https://www.pharmaceutical-business-review.com/news/laquinimod-trial-for-ms-treatment-yields-positive-results-191011/ 2011-10-19T08:02:00+00:00 https://www.pharmaceutical-business-review.com/news/allegiance-health-adopts-new-automation-solutions-by-mckesson-201011/ 2011-10-19T21:49:00+00:00 https://www.pharmaceutical-business-review.com/news/pacira-exparel-yields-positive-data-in-opioid-burdens-reduction-201011/ 2011-10-20T00:48:00+00:00 https://www.pharmaceutical-business-review.com/news/insight-pharmaceuticals-recalls-nasal-decongestant-over-bacterial-contamination-201011/ 2011-10-20T00:57:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-b-braun-introcan-safety-3-catheter-201011/ 2011-10-20T01:21:00+00:00 https://www.pharmaceutical-business-review.com/news/perrigo-enters-deal-with-founder-group-to-expand-infant-formula-distribution-in-china-201011/ 2011-10-20T02:09:00+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-grants-approval-to-use-byetta-with-insulin-glargine-201011/ 2011-10-20T02:22:00+00:00 https://www.pharmaceutical-business-review.com/news/sk-medicilon-sign-research-agreement-on-skl-psy-to-treat-depression-201011/ 2011-10-20T03:22:00+00:00 https://www.pharmaceutical-business-review.com/news/eu-grants-anticalin-therapeutic-development-fund-to-eurocalin-consortium-201011/ 2011-10-20T03:26:00+00:00 https://www.pharmaceutical-business-review.com/news/niaid-awards-contract-for-preclinical-services-201011/ 2011-10-20T05:43:00+00:00 https://www.pharmaceutical-business-review.com/news/hovione-enters-cooperative-collaboration-with-bend-research-201011/ 2011-10-20T06:51:00+00:00 https://www.pharmaceutical-business-review.com/news/nutra-pharma-wins-patent-for-ms-drug-201011/ 2011-10-20T06:56:00+00:00 https://www.pharmaceutical-business-review.com/news/vaxygen-gsurf-enter-deal-for-biological-process-development-patent-201011/ 2011-10-20T07:00:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmagap-completes-audits-at-manufacturer-site-201011/ 2011-10-20T07:05:00+00:00 https://www.pharmaceutical-business-review.com/news/galderma-reports-positive-phase-2b-trial-results-of-topical-gel-201011/ 2011-10-20T07:13:00+00:00 https://www.pharmaceutical-business-review.com/news/vertex-files-cystic-fibrosis-drug-nda-with-fda-201011/ 2011-10-20T07:19:00+00:00 https://www.pharmaceutical-business-review.com/news/emd-serono-fast-forward-join-forces-to-develop-therapies-for-ms-201011/ 2011-10-20T07:27:00+00:00 https://www.pharmaceutical-business-review.com/news/ffg-offers-grant-to-arsanis-for-monoclonal-antibodies-development-201011/ 2011-10-20T07:31:00+00:00 https://www.pharmaceutical-business-review.com/news/thermo-fisher-introduces-drop-plate-for-nucleic-acid-assay-211011/ 2011-10-20T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-adopts-freeslate-automation-solutions-211011/ 2011-10-20T22:44:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-announces-positive-data-of-copaxone-in-eae-treatment-211011/ 2011-10-21T00:45:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-selects-patheon-for-drug-development-211011/ 2011-10-21T00:50:00+00:00 https://www.pharmaceutical-business-review.com/news/pharma-industry-needs-to-transform-investment-and-business-strategies-report-211011/ 2011-10-21T02:14:00+00:00 https://www.pharmaceutical-business-review.com/news/rituximab-proven-to-treat-mecfs-211011/ 2011-10-21T02:46:00+00:00 https://www.pharmaceutical-business-review.com/news/syntaxin-ipsen-to-develop-botulinum-toxin-therapeutics-211011/ 2011-10-21T02:58:00+00:00 https://www.pharmaceutical-business-review.com/news/sartorius-stedim-biotech-adds-new-product-to-flexel-range-211011/ 2011-10-21T03:08:00+00:00 https://www.pharmaceutical-business-review.com/news/basf-partners-colorcon-to-develop-film-coating-systems-211011/ 2011-10-21T03:12:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-sagent-bupivacaine-hydrochloride-injection-211011/ 2011-10-21T03:54:00+00:00 https://www.pharmaceutical-business-review.com/news/taj-pharma-receives-fda-approval-to-manufacture-papaverine-211011/ 2011-10-21T04:05:00+00:00 https://www.pharmaceutical-business-review.com/news/almac-to-expand-pharmaceutical-facilities-211011/ 2011-10-21T07:14:00+00:00 https://www.pharmaceutical-business-review.com/news/amarantus-gets-us-patent-for-apoptosis-drug-211011/ 2011-10-21T07:22:00+00:00 https://www.pharmaceutical-business-review.com/news/radient-files-cancer-test-patent-in-china-japan-241011/ 2011-10-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/us-imposes-ban-on-bath-salts-chemicals-241011/ 2011-10-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/advancedmd-modernizing-medicine-launch-new-cloud-solution-241011/ 2011-10-23T20:55:00+00:00 https://www.pharmaceutical-business-review.com/news/global-rights-to-safinamide-return-to-newron-from-merck-serono-241011/ 2011-10-24T00:58:00+00:00 https://www.pharmaceutical-business-review.com/news/cephalon-returns-lupuzor-rights-to-immupharma-241011/ 2011-10-24T01:08:00+00:00 https://www.pharmaceutical-business-review.com/news/biogen-oral-bg-12-trial-demonstrates-efficacy-in-rrms-treatment-241011/ 2011-10-24T01:12:00+00:00 https://www.pharmaceutical-business-review.com/news/xencor-begins-xmab5871-phase-1-study-to-treat-autoimmune-diseases-241011/ 2011-10-24T02:10:00+00:00 https://www.pharmaceutical-business-review.com/news/dynavax-extends-alliance-with-glaxosmithkline-241011/ 2011-10-24T02:14:00+00:00 https://www.pharmaceutical-business-review.com/news/ferring-euflexxa-receives-fda-approval-241011/ 2011-10-24T02:20:00+00:00 https://www.pharmaceutical-business-review.com/news/watson-testosterone-transdermal-delivery-system-wins-fda-approval-241011/ 2011-10-24T02:30:00+00:00 https://www.pharmaceutical-business-review.com/news/halozyme-ultrafast-insulin-trials-in-diabetics-yield-positive-data-251011/ 2011-10-24T05:10:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-boca-glycopyrrolate-tablet-anda-241011/ 2011-10-24T05:19:00+00:00 https://www.pharmaceutical-business-review.com/news/prezista-receives-fda-approval-for-label-update-241011/ 2011-10-24T05:23:00+00:00 https://www.pharmaceutical-business-review.com/news/athersys-fast-forward-to-develop-multistem-for-ms-treatment-241011/ 2011-10-24T05:30:00+00:00 https://www.pharmaceutical-business-review.com/news/true-healthy-products-introduces-pain-relief-products-241011/ 2011-10-24T06:24:00+00:00 https://www.pharmaceutical-business-review.com/news/naturex-acquires-burgundy-botanical-extracts-241011/ 2011-10-24T06:54:00+00:00 https://www.pharmaceutical-business-review.com/news/shire-reports-lisdexamfetamine-dimesylate-positive-phase-iii-results-241011/ 2011-10-24T08:01:00+00:00 https://www.pharmaceutical-business-review.com/news/wuxi-pharmatech-takesover-clinical-research-services-companies-241011/ 2011-10-24T08:07:00+00:00 https://www.pharmaceutical-business-review.com/news/apelon-introduces-new-mapping-solution-251011/ 2011-10-24T23:26:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-ain457-demonstrates-efficacy-in-psoriasis-treatment-251011/ 2011-10-25T01:02:00+00:00 https://www.pharmaceutical-business-review.com/news/genzyme-appoints-david-meeker-as-new-ceo-251011/ 2011-10-25T01:07:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-anda-for-lannett-diethylpropion-hcl-tablets-251011/ 2011-10-25T01:16:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-dulera-shows-efficacy-in-copd-treatment-251011/ 2011-10-25T01:27:00+00:00 https://www.pharmaceutical-business-review.com/news/cubist-to-acquire-adolor-251011/ 2011-10-25T01:32:00+00:00 https://www.pharmaceutical-business-review.com/news/intrexon-acquires-immunologix-251011/ 2011-10-25T01:57:00+00:00 https://www.pharmaceutical-business-review.com/news/almac-set-to-expand-api-manufacturing-251011/ 2011-10-25T02:02:00+00:00 https://www.pharmaceutical-business-review.com/news/ironwood-forest-announce-fda-approval-for-linaclotide-nda-251011/ 2011-10-25T02:13:00+00:00 https://www.pharmaceutical-business-review.com/news/progenra-signs-deal-with-tokyo-medical-university-over-ra-research-251011/ 2011-10-25T02:52:00+00:00 https://www.pharmaceutical-business-review.com/news/silence-mirna-to-develop-microrna-therapeutics-251011/ 2011-10-25T03:03:00+00:00 https://www.pharmaceutical-business-review.com/news/almirall-announces-positive-phase-iii-data-of-sativex-251011/ 2011-10-25T06:24:00+00:00 https://www.pharmaceutical-business-review.com/news/goodwin-spectros-join-forces-for-cgmp-manufacturing-of-antibody-251011/ 2011-10-25T06:31:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-globeimmune-partner-for-hepatitis-b-vaccine-development-251011/ 2011-10-25T06:41:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-uk-subsidiary-introduces-rivastigmine-capsules-251011/ 2011-10-25T07:15:00+00:00 https://www.pharmaceutical-business-review.com/news/biostar-takesover-shaanxi-weinan-huaren-pharmaceuticals-251011/ 2011-10-25T08:18:00+00:00 https://www.pharmaceutical-business-review.com/news/thallion-reports-low-dose-cohort-phase-ii-shigatec-study-results-251011/ 2011-10-25T08:36:00+00:00 https://www.pharmaceutical-business-review.com/news/lonza-genmab-sign-manufacturing-agreement-for-antibody-drug-conjugate-261011/ 2011-10-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/molmed-expands-ngr-htnf-trial-in-the-us-261011/ 2011-10-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/basilea-completes-bal30072-phase-i-trial-261011/ 2011-10-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/atox-bio-secures-orphan-drug-designation-for-ab103-261011/ 2011-10-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/probiogen-inhibrx-enter-license-deal-on-glymaxx-adcc-technology-261011/ 2011-10-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/apeptico-concludes-ap301-phase-i-trial-in-oedematous-respiratory-failure-261011/ 2011-10-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/verisys-introduces-new-online-credentialing-system-261011/ 2011-10-25T22:36:00+00:00 https://www.pharmaceutical-business-review.com/news/breast-cancer-research-foundation-awards-grant-to-university-of-michigan-261011/ 2011-10-26T01:43:00+00:00 https://www.pharmaceutical-business-review.com/news/dynavax-reports-positive-phase-3-studies-of-heplisav-261011/ 2011-10-26T03:57:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-dr-reddys-introduce-generic-versions-of-zyprexa-261011/ 2011-10-26T04:00:00+00:00 https://www.pharmaceutical-business-review.com/news/msi-vtt-enter-joint-research-collaboration-261011/ 2011-10-26T04:10:00+00:00 https://www.pharmaceutical-business-review.com/news/adams-knight-to-market-pfizer-viagra-brand-in-middle-east-africa-261011/ 2011-10-26T04:13:00+00:00 https://www.pharmaceutical-business-review.com/news/pacgen-names-ming-liu-as-new-ceo-261011/ 2011-10-26T04:20:00+00:00 https://www.pharmaceutical-business-review.com/news/thomson-reuters-introduces-new-intelligence-tool-for-life-sciences-industry-271011/ 2011-10-26T23:22:00+00:00 https://www.pharmaceutical-business-review.com/news/biogen-idec-abbott-present-efficacy-data-of-dac-hyp-in-rrms-treatment-271011/ 2011-10-27T01:11:00+00:00 https://www.pharmaceutical-business-review.com/news/txcell-announces-positive-results-of-ovasave-in-crohns-disease-271011/ 2011-10-27T01:15:00+00:00 https://www.pharmaceutical-business-review.com/news/kempharm-to-develop-new-pain-therapy-drug-271011/ 2011-10-27T01:39:00+00:00 https://www.pharmaceutical-business-review.com/news/ashland-introduces-new-drug-release-excipients-271011/ 2011-10-27T03:30:00+00:00 https://www.pharmaceutical-business-review.com/news/cmc-biologics-daiichi-sankyo-enter-deal-to-manufacture-antibodies-271011/ 2011-10-27T03:39:00+00:00 https://www.pharmaceutical-business-review.com/news/uk-dh-extends-childhood-vaccines-contract-with-movianto-271011/ 2011-10-27T03:47:00+00:00 https://www.pharmaceutical-business-review.com/news/solasia-initiates-darinaparsin-injection-phase-i-trial-in-japan-271011/ 2011-10-27T04:48:00+00:00 https://www.pharmaceutical-business-review.com/news/ic-places-to-distribute-pit-bull-energy-drinks-and-health-products-online-271011/ 2011-10-27T05:05:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-investigational-colorectal-cancer-drug-meets-primary-endpoint-271011/ 2011-10-27T05:11:00+00:00 https://www.pharmaceutical-business-review.com/news/ihl-introduces-new-supplements-271011/ 2011-10-27T06:22:00+00:00 https://www.pharmaceutical-business-review.com/news/ec-approves-extended-use-of-prevenar-13-for-adults-271011/ 2011-10-27T06:35:00+00:00 https://www.pharmaceutical-business-review.com/news/ashland-to-introduce-new-gmp-hot-melt-extruder-271011/ 2011-10-27T06:51:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-mylan-morphine-sulfate-er-tablets-anda-271011/ 2011-10-27T07:03:00+00:00 https://www.pharmaceutical-business-review.com/news/quintiles-to-acquire-advion-bioservices-271011/ 2011-10-27T07:12:00+00:00 https://www.pharmaceutical-business-review.com/news/cytheris-to-announce-eclipse-ii-hepatitis-c-study-data-at-aasld-meeting-271011/ 2011-10-27T07:29:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-gilead-sciences-join-forces-for-hiv-treatment-271011/ 2011-10-27T07:47:00+00:00 https://www.pharmaceutical-business-review.com/news/xoma-enters-antibody-humanization-services-deal-with-aragen-271011/ 2011-10-27T07:58:00+00:00 https://www.pharmaceutical-business-review.com/news/asuragen-unveils-xpansion-interpreter-281011/ 2011-10-27T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/sanford-usd-medical-center-selects-mckesson-automation-solution-281011/ 2011-10-27T21:59:00+00:00 https://www.pharmaceutical-business-review.com/news/rusnano-co-invests-in-selecta-bind-for-drug-development-in-russia-281011/ 2011-10-28T00:58:00+00:00 https://www.pharmaceutical-business-review.com/news/halozyme-reports-positive-pegph20-phase-1-studies-data-281011/ 2011-10-28T01:05:00+00:00 https://www.pharmaceutical-business-review.com/news/activartis-develops-dendritic-cell-based-cancer-vaccine-281011/ 2011-10-28T01:12:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-submits-nda-for-the-quad-281011/ 2011-10-28T01:22:00+00:00 https://www.pharmaceutical-business-review.com/news/abbott-introduces-nutrition-products-for-diabetics-281011/ 2011-10-28T03:33:00+00:00 https://www.pharmaceutical-business-review.com/news/cannabis-science-introduces-cannabis-extract-based-formulation-281011/ 2011-10-28T03:44:00+00:00 https://www.pharmaceutical-business-review.com/news/alexza-submits-adasuve-maa-to-ema-281011/ 2011-10-28T05:27:00+00:00 https://www.pharmaceutical-business-review.com/news/ucl-secures-who-certification-plans-to-enter-global-drugs-market-281011/ 2011-10-28T06:08:00+00:00 https://www.pharmaceutical-business-review.com/news/nupathe-zelrix-patch-receives-fda-rejection-281011/ 2011-10-28T06:17:00+00:00 https://www.pharmaceutical-business-review.com/news/marijuana-introduces-new-kushclear-nutraceutical-product-line-281011/ 2011-10-28T06:27:00+00:00 https://www.pharmaceutical-business-review.com/news/repligen-acquires-novozymes-281011/ 2011-10-28T06:49:00+00:00 https://www.pharmaceutical-business-review.com/news/safc-launches-new-cell-line-for-biopharmaceutical-production-281011/ 2011-10-28T07:02:00+00:00 https://www.pharmaceutical-business-review.com/news/bio-medicine-science-park-opens-in-china-281011/ 2011-10-28T07:08:00+00:00 https://www.pharmaceutical-business-review.com/news/use-of-otc-thyroid-support-pills-poses-health-risk-study-281011/ 2011-10-28T07:35:00+00:00 https://www.pharmaceutical-business-review.com/news/meda-files-dymista-maa-in-europe-281011/ 2011-10-28T07:44:00+00:00 https://www.pharmaceutical-business-review.com/news/avanir-submits-nuedexta-maa-to-ema-311011/ 2011-10-30T23:32:00+00:00 https://www.pharmaceutical-business-review.com/news/iatric-systems-unveils-new-healthcare-interface-engine-311011/ 2011-10-31T01:02:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-acquires-icagen-311011/ 2011-10-31T01:08:00+00:00 https://www.pharmaceutical-business-review.com/news/atlab-bzl-biologics-join-forces-to-develop-lu-j591-for-cancer-treatment-311011/ 2011-10-31T01:12:00+00:00 https://www.pharmaceutical-business-review.com/news/us-court-grants-plea-to-prevent-sale-of-enoxaparin-by-watson-amphastar-311011/ 2011-10-31T01:14:00+00:00 https://www.pharmaceutical-business-review.com/news/ec-grants-approval-for-alimta-in-nsclc-treatment-311011/ 2011-10-31T01:17:00+00:00 https://www.pharmaceutical-business-review.com/news/oxford-biomedica-mayo-clinic-enter-research-collaboration-311011/ 2011-10-31T03:42:00+00:00 https://www.pharmaceutical-business-review.com/news/oxea-to-set-up-oxo-derivatives-plant-in-china-311011/ 2011-10-31T03:45:00+00:00 https://www.pharmaceutical-business-review.com/news/foundation-fighting-blindness-funds-gene-therapy-development-311011/ 2011-10-31T03:51:00+00:00 https://www.pharmaceutical-business-review.com/news/protagen-enters-strategic-alliance-with-charles-river-311011/ 2011-10-31T03:52:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-pacira-post-surgical-pain-management-product-311011/ 2011-10-31T05:48:00+00:00 https://www.pharmaceutical-business-review.com/news/vegenics-receives-fda-ind-clearance-for-vgx-100-drug-trial-311011/ 2011-10-31T06:35:00+00:00 https://www.pharmaceutical-business-review.com/news/bergenbio-commences-preclinical-development-of-bgb324-311011/ 2011-10-31T06:37:00+00:00 https://www.pharmaceutical-business-review.com/news/astex-to-present-data-on-hepatitis-c-virus-drug-311011/ 2011-10-31T06:42:00+00:00 https://www.pharmaceutical-business-review.com/news/lilly-announces-30m-additional-funds-to-fight-tb-311011/ 2011-10-31T06:43:00+00:00 https://www.pharmaceutical-business-review.com/news/hal-allergy-begins-patient-enrollment-for-phase-ii-purethal-mites-study-311011/ 2011-10-31T06:48:00+00:00 https://www.pharmaceutical-business-review.com/news/alios-biopharma-inks-licensing-agreement-with-versitech-for-influenza-technology-311011/ 2011-10-31T06:51:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-wins-fda-pma-for-acute-hepatitis-b-test-011111/ 2011-10-31T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/perkinelmer-unveils-new-nexion-enhanced-security-software-011111/ 2011-10-31T18:57:00+00:00 https://www.pharmaceutical-business-review.com/news/trophos-begins-phase-ii-proof-of-concept-study-for-tro40303-011111/ 2011-10-31T23:54:00+00:00 https://www.pharmaceutical-business-review.com/news/celldex-receives-orphan-drug-designation-for-rindopepimut-011111/ 2011-11-01T00:09:00+00:00 https://www.pharmaceutical-business-review.com/news/genedata-unveils-protein-production-data-management-software-011111/ 2011-11-01T00:13:00+00:00 https://www.pharmaceutical-business-review.com/news/infinity-begins-two-phase-1-ipi-145-trials-011111/ 2011-11-01T00:18:00+00:00 https://www.pharmaceutical-business-review.com/news/jj-submits-snda-for-nucynta-er-011111/ 2011-11-01T00:24:00+00:00 https://www.pharmaceutical-business-review.com/news/azantis-launches-new-krill-oil-blend-011111/ 2011-11-01T00:50:00+00:00 https://www.pharmaceutical-business-review.com/news/exelixis-to-begin-cabozantinib-phase-3-trial-011111/ 2011-11-01T02:22:00+00:00 https://www.pharmaceutical-business-review.com/news/isperse-shows-superiority-in-multi-drug-inhaled-dose-delivery-011111/ 2011-11-01T04:36:00+00:00 https://www.pharmaceutical-business-review.com/news/skin-all-natural-adds-eczema-relief-cream-to-product-line-011111/ 2011-11-01T05:31:00+00:00 https://www.pharmaceutical-business-review.com/news/vitamin-wagon-adds-ehgh-to-product-line-011111/ 2011-11-01T05:38:00+00:00 https://www.pharmaceutical-business-review.com/news/cytrx-reports-positive-safety-data-for-inno-206-011111/ 2011-11-01T06:39:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-intellipharmaceutics-generic-lamictal-anda-011111/ 2011-11-01T06:46:00+00:00 https://www.pharmaceutical-business-review.com/news/endo-pharma-moves-headquarters-to-malvern-011111/ 2011-11-01T06:53:00+00:00 https://www.pharmaceutical-business-review.com/news/hawaii-biotech-acquires-vaccine-technology-license-from-merck-011111/ 2011-11-01T06:57:00+00:00 https://www.pharmaceutical-business-review.com/news/uk-funds-domainex-for-cancer-drug-development-011111/ 2011-11-01T07:02:00+00:00 https://www.pharmaceutical-business-review.com/news/dara-reports-diabetes-drug-phase-1b-positive-trial-results-011111/ 2011-11-01T07:32:00+00:00 https://www.pharmaceutical-business-review.com/news/alnylam-glaxosmithkline-join-forces-for-vaccine-production-021111/ 2011-11-01T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-grants-noa-to-epitomics-protein-expression-method-021111/ 2011-11-02T00:16:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-vgti-in-research-collaboration-021111/ 2011-11-02T00:32:00+00:00 https://www.pharmaceutical-business-review.com/news/nuron-starts-rrms-drug-phase-3-trail/ 2011-11-02T02:19:00+00:00 https://www.pharmaceutical-business-review.com/news/perrigo-patner-wins-final-approval-for-generic-elesta-021111/ 2011-11-02T03:04:00+00:00 https://www.pharmaceutical-business-review.com/news/nanosmart-childrens-hospital-partner-to-develop-cancer-drug-delivery-system-021111/ 2011-11-02T04:24:00+00:00 https://www.pharmaceutical-business-review.com/news/evonik-to-acquire-surmodics-pharmaceutical-assets-021111/ 2011-11-02T05:55:00+00:00 https://www.pharmaceutical-business-review.com/news/cytokinetics-starts-als-drug-phase-ii-second-cohort-study-021111/ 2011-11-02T06:40:00+00:00 https://www.pharmaceutical-business-review.com/news/exonhit-allergan-in-extended-drug-discovery-collaboration-agreement-021111/ 2011-11-02T06:45:00+00:00 https://www.pharmaceutical-business-review.com/news/neutra-names-cindy-morrissey-as-new-ceo-02/ 2011-11-02T06:57:00+00:00 https://www.pharmaceutical-business-review.com/news/isis-pharma-starts-diabetes-drugs-phase-1-trial-021111/ 2011-11-02T07:29:00+00:00 https://www.pharmaceutical-business-review.com/news/optimer-files-nds-for-dificid-in-canada-031111/ 2011-11-02T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/baxa-releases-software-upgrade-for-exactamix-acd-031111/ 2011-11-02T23:20:00+00:00 https://www.pharmaceutical-business-review.com/news/perrigo-files-nda-for-testosterone-gel-031111/ 2011-11-03T00:04:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-approval-to-strides-doxorubicin-hydrochloride-injection-031111/ 2011-11-03T00:08:00+00:00 https://www.pharmaceutical-business-review.com/news/ligand-reports-positive-data-for-captisol-enabled-melphalan-drug-031111/ 2011-11-03T00:13:00+00:00 https://www.pharmaceutical-business-review.com/news/vertex-announces-efficacy-data-of-kalydeco-against-cystic-fibrosis-031111/ 2011-11-03T00:30:00+00:00 https://www.pharmaceutical-business-review.com/news/novasep-unveils-new-generation-protein-a-media-031111/ 2011-11-03T00:35:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-generic-version-of-plendil-xr-tablets-031111/ 2011-11-03T02:40:00+00:00 https://www.pharmaceutical-business-review.com/news/ec-grants-orphan-drug-status-to-bioalliance-clonidine-lauriad-031111/ 2011-11-03T02:43:00+00:00 https://www.pharmaceutical-business-review.com/news/ipsen-sells-apokyn-development-and-marketing-rights-to-britannia-pharmaceuticals-031111/ 2011-11-03T02:47:00+00:00 https://www.pharmaceutical-business-review.com/news/amrion-unveils-stress-relief-solution-031111/ 2011-11-03T02:53:00+00:00 https://www.pharmaceutical-business-review.com/news/cprit-grants-funds-for-cancer-research-031111/ 2011-11-03T03:51:00+00:00 https://www.pharmaceutical-business-review.com/news/morphosys-extends-license-agreement-with-shionogi-031111/ 2011-11-03T04:22:00+00:00 https://www.pharmaceutical-business-review.com/news/tau-scynexis-pharmadirections-jointly-work-for-mibefradil-development-031111/ 2011-11-03T05:01:00+00:00 https://www.pharmaceutical-business-review.com/news/clinuvel-reports-photoprotective-drug-first-phase-ii-positive-results-031111/ 2011-11-03T05:52:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-submits-maa-for-lyxumia-031111/ 2011-11-03T06:47:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-approval-to-immupharma-lupuzor-to-begin-phase-iii-trial-031111/ 2011-11-03T06:52:00+00:00 https://www.pharmaceutical-business-review.com/news/aslan-bristol-myers-in-investigational-oncology-drug-development-031111/ 2011-11-03T06:57:00+00:00 https://www.pharmaceutical-business-review.com/news/hylands-releases-new-products-for-cough-and-cold-031111/ 2011-11-03T07:00:00+00:00 https://www.pharmaceutical-business-review.com/news/premier-partners-orders-for-z-medica-quikclot-hemostatic-products-041111/ 2011-11-03T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/hgs-selects-veeva-crm-to-support-launch-of-lupus-drug-in-europe-041111/ 2011-11-03T20:56:00+00:00 https://www.pharmaceutical-business-review.com/news/oxigene-zybrestat-shows-efficacy-in-nsclc-treatment-041111/ 2011-11-03T23:59:00+00:00 https://www.pharmaceutical-business-review.com/news/auxilium-testim-shows-improved-sexual-function-in-hypogonadal-men-031111/ 2011-11-04T00:23:00+00:00 https://www.pharmaceutical-business-review.com/news/tianyin-to-expand-formulation-for-gmol-041111/ 2011-11-04T00:32:00+00:00 https://www.pharmaceutical-business-review.com/news/aoxing-receives-funds-to-improve-manufacturing-facility-041111/ 2011-11-04T01:01:00+00:00 https://www.pharmaceutical-business-review.com/news/adamis-apc-100-secures-allowance-for-patent-in-canada-041111/ 2011-11-04T02:58:00+00:00 https://www.pharmaceutical-business-review.com/news/vivus-qnexa-secures-fda-approval-for-nda-filing-041111/ 2011-11-04T03:01:00+00:00 https://www.pharmaceutical-business-review.com/news/senesco-begins-sns01-t-drug-trial-041111/ 2011-11-04T05:59:00+00:00 https://www.pharmaceutical-business-review.com/news/mir-15-family-inhibitor-proven-effective-against-ischemic-cardiac-injury-041111/ 2011-11-04T06:04:00+00:00 https://www.pharmaceutical-business-review.com/news/ablynx-regains-anti-tnf-alpha-nanobody-rights-from-pfizer-041111/ 2011-11-04T06:49:00+00:00 https://www.pharmaceutical-business-review.com/news/celgene-quanticel-to-develop-cancer-drugs-041111/ 2011-11-04T06:53:00+00:00 https://www.pharmaceutical-business-review.com/news/avanir-enrolls-first-patient-in-prime-study-041111/ 2011-11-04T07:00:00+00:00 https://www.pharmaceutical-business-review.com/news/regenerx-eye-drops-treat-dry-eye-syndrome-in-study-041111/ 2011-11-04T07:49:00+00:00 https://www.pharmaceutical-business-review.com/news/forte-releases-new-allegro-ctmssite-071111/ 2011-11-06T20:04:00+00:00 https://www.pharmaceutical-business-review.com/news/humira-plus-mtx-proven-effective-in-rheumatoid-arthritis-071111/ 2011-11-07T00:43:00+00:00 https://www.pharmaceutical-business-review.com/news/idera-raises-95m-071111/ 2011-11-07T00:46:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-janssen-once-daily-anti-coagulant-071111/ 2011-11-07T00:50:00+00:00 https://www.pharmaceutical-business-review.com/news/neutra-sources-materials-nutraceutical-products-071111/ 2011-11-07T01:39:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-viread-drug-proven-effective-against-hbv-infection-071111/ 2011-11-07T01:42:00+00:00 https://www.pharmaceutical-business-review.com/news/vx-509-proven-effective-in-ra-treatment-vertex-study-071111/ 2011-11-07T05:36:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-reports-efficacy-of-prolia-in-increasing-bone-mineral-density-071111/ 2011-11-07T05:41:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-reports-efficacy-of-incivo-in-cirrhotic-patients-071111/ 2011-11-07T06:51:00+00:00 https://www.pharmaceutical-business-review.com/news/cv9201-proven-effective-in-nsclc-curevac-study-071111/ 2011-11-07T06:54:00+00:00 https://www.pharmaceutical-business-review.com/news/cyprotex-to-expand-us-based-facility-071111/ 2011-11-07T07:03:00+00:00 https://www.pharmaceutical-business-review.com/news/alchemia-to-set-up-new-oncology-business-071111/ 2011-11-07T07:07:00+00:00 https://www.pharmaceutical-business-review.com/news/biopharm-astra-zeneca-to-enter-anticancer-drugs-production-deal-071111/ 2011-11-07T07:14:00+00:00 https://www.pharmaceutical-business-review.com/news/conway-medical-center-adopts-patientkeeper-automation-solutions-081111/ 2011-11-07T22:34:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-deb025-proven-as-effective-interferon-free-therapy-in-hepatitis-c-081111/ 2011-11-08T00:25:00+00:00 https://www.pharmaceutical-business-review.com/news/ucb-reports-response-to-cimzia-in-ra-081111/ 2011-11-08T00:34:00+00:00 https://www.pharmaceutical-business-review.com/news/nanostring-closes-20m-in-series-d-equity-financing-081111/ 2011-11-08T00:38:00+00:00 https://www.pharmaceutical-business-review.com/news/ec-grants-ema-to-duocort-plenadren-081111/ 2011-11-08T00:46:00+00:00 https://www.pharmaceutical-business-review.com/news/acadia-meiji-seika-pharma-collaborate-on-am-831-drug-study-081111/ 2011-11-08T00:51:00+00:00 https://www.pharmaceutical-business-review.com/news/ajinomoto-plans-expansion-of-feed-amino-acids-capacity-081111/ 2011-11-08T02:09:00+00:00 https://www.pharmaceutical-business-review.com/news/utah-college-of-pharmacy-wins-research-grant-for-epilepsy-treatment-081111/ 2011-11-08T03:59:00+00:00 https://www.pharmaceutical-business-review.com/news/adeona-enters-wellzin-manufacturing-and-supply-deal-with-ff-foods-081111/ 2011-11-08T04:09:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-presents-sound-c2-data-on-hcv-antivirals-071111/ 2011-11-08T04:55:00+00:00 https://www.pharmaceutical-business-review.com/news/ancor-acquires-us-based-pharmaceutical-firm-081111/ 2011-11-08T05:07:00+00:00 https://www.pharmaceutical-business-review.com/news/healthient-launches-new-energy-drink-mix-081111/ 2011-11-08T05:09:00+00:00 https://www.pharmaceutical-business-review.com/news/quinnova-unveils-neosalus-lotion-for-skin-repair-081111/ 2011-11-08T05:15:00+00:00 https://www.pharmaceutical-business-review.com/news/grand-challenges-explorations-funds-ptc-therapeutics-research-081111/ 2011-11-08T06:27:00+00:00 https://www.pharmaceutical-business-review.com/news/npsp558-proven-effective-in-hypoparathyroidism-nps-study-081111/ 2011-11-08T06:47:00+00:00 https://www.pharmaceutical-business-review.com/news/dako-bristol-myers-in-pharmacodiagnostic-tests-development-agreement-091111/ 2011-11-08T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/target-health-lifeonkey-integrate-edc-emr-in-clinical-trial-091111/ 2011-11-08T22:49:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-targacept-report-top-line-data-from-phase-iii-trial-of-tc-5214-091111/ 2011-11-09T00:02:00+00:00 https://www.pharmaceutical-business-review.com/news/cytheris-presents-interim-results-from-eclipse-ii-study-of-il-7-091111/ 2011-11-09T00:07:00+00:00 https://www.pharmaceutical-business-review.com/news/salix-inks-deal-to-acquire-oceana-therapeutics-operating-unit-091111/ 2011-11-09T00:18:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-fast-track-designation-to-opexa-tovaxin-091111/ 2011-11-09T01:04:00+00:00 https://www.pharmaceutical-business-review.com/news/perrigo-to-expand-infant-formula-distribution-in-china-091111/ 2011-11-09T01:12:00+00:00 https://www.pharmaceutical-business-review.com/news/netherlands-supports-orca-cancer-therapy-development-091111/ 2011-11-09T01:21:00+00:00 https://www.pharmaceutical-business-review.com/news/nih-awards-funding-to-labcyte-for-biomarker-validation-program-091111/ 2011-11-09T04:27:00+00:00 https://www.pharmaceutical-business-review.com/news/barda-grants-15m-contract-to-rxbio-091111/ 2011-11-09T04:33:00+00:00 https://www.pharmaceutical-business-review.com/news/merrick-receives-commissioning-contracts-091111/ 2011-11-09T04:39:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-intravenous-cetuximab-091111/ 2011-11-09T04:45:00+00:00 https://www.pharmaceutical-business-review.com/news/access-strikes-deal-over-rnai-therapeutic-delivery-091111/ 2011-11-09T05:50:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-receives-fda-acceptance-for-vismodegib-nda-091111/ 2011-11-09T06:01:00+00:00 https://www.pharmaceutical-business-review.com/news/tibotec-to-announce-positive-tmc435-data-in-hcv-infected-patients-091111/ 2011-11-09T06:10:00+00:00 https://www.pharmaceutical-business-review.com/news/ucb-unveils-efficacy-data-of-cimzia-in-ra-patients-091111/ 2011-11-09T06:19:00+00:00 https://www.pharmaceutical-business-review.com/news/epratuzumab-trial-showed-sensitivity-of-bicla-in-sle-091111/ 2011-11-09T06:45:00+00:00 https://www.pharmaceutical-business-review.com/news/jcm-meets-quality-standards-for-azithromycin-api-production-091111/ 2011-11-09T07:23:00+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-kyorin-in-collaboration-agreement-091111/ 2011-11-09T08:10:00+00:00 https://www.pharmaceutical-business-review.com/news/sedgwick-county-health-center-selects-prognosis-ehr-solution-101111/ 2011-11-09T23:34:00+00:00 https://www.pharmaceutical-business-review.com/news/ablynx-extends-osteoarthritis-deal-with-merck-101111/ 2011-11-09T23:46:00+00:00 https://www.pharmaceutical-business-review.com/news/tranzyme-expands-drug-discovery-agreement-with-bristol-myers-squibb-101111/ 2011-11-09T23:52:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-releases-contraceptive-nexplanon-in-us-101111/ 2011-11-09T23:57:00+00:00 https://www.pharmaceutical-business-review.com/news/alkermes-vivitrol-proven-effective-in-opioid-dependence-treatment-101111/ 2011-11-10T01:29:00+00:00 https://www.pharmaceutical-business-review.com/news/anacor-concludes-patient-enrollment-for-tavaborole-trial-101111/ 2011-11-10T01:34:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-sciences-crf-commence-ranolazine-trial-to-treat-mace-101111/ 2011-11-10T01:39:00+00:00 https://www.pharmaceutical-business-review.com/news/url-pharma-reports-efficacy-and-safety-data-of-colchicine-101111/ 2011-11-10T01:57:00+00:00 https://www.pharmaceutical-business-review.com/news/intellect-receives-japanese-patents-for-alzheimers-treatment-101111/ 2011-11-10T02:08:00+00:00 https://www.pharmaceutical-business-review.com/news/amri-strikes-supply-and-manufacturing-deal-with-revolymer-101111/ 2011-11-10T04:19:00+00:00 https://www.pharmaceutical-business-review.com/news/corning-life-sciences-opens-manufacturing-and-distribution-facility-in-china-101111/ 2011-11-10T04:27:00+00:00 https://www.pharmaceutical-business-review.com/news/nippon-to-adopt-accelrys-eln-101111/ 2011-11-10T04:37:00+00:00 https://www.pharmaceutical-business-review.com/news/vaxygen-introduces-bioassay-services-and-operations-101111/ 2011-11-10T04:56:00+00:00 https://www.pharmaceutical-business-review.com/news/fahrenheit-nutrition-releases-fat-burning-formulation-101111/ 2011-11-10T05:10:00+00:00 https://www.pharmaceutical-business-review.com/news/cyprotex-enhances-pharmacokinetic-prediction-software-platform-101111/ 2011-11-10T06:24:00+00:00 https://www.pharmaceutical-business-review.com/news/verona-reports-copd-drug-positive-phase-iia-study-results-101111/ 2011-11-10T06:57:00+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-arqule-in-license-agreement-101111/ 2011-11-10T07:07:00+00:00 https://www.pharmaceutical-business-review.com/news/wolters-to-sell-pharma-related-business-to-springer-101111/ 2011-11-10T07:22:00+00:00 https://www.pharmaceutical-business-review.com/news/vista-equity-partners-acquires-sage-healthcare-division-111111/ 2011-11-10T21:07:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-funds-nccn-oncology-research-program-111111/ 2011-11-11T00:11:00+00:00 https://www.pharmaceutical-business-review.com/news/baxter-acquires-baxa-111111/ 2011-11-11T00:26:00+00:00 https://www.pharmaceutical-business-review.com/news/santen-sirolimus-drug-secures-fda-orphan-drug-status-111111/ 2011-11-11T00:34:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-watson-anda-for-kadian-111111/ 2011-11-11T00:41:00+00:00 https://www.pharmaceutical-business-review.com/news/otsuka-h-lundbeck-to-develop-neuroscience-products-111111/ 2011-11-11T02:20:00+00:00 https://www.pharmaceutical-business-review.com/news/epistem-joins-university-of-manchester-for-wound-healing-111111/ 2011-11-11T02:26:00+00:00 https://www.pharmaceutical-business-review.com/news/napo-terminates-collaboration-agreement-with-salix-111111/ 2011-11-11T05:05:00+00:00 https://www.pharmaceutical-business-review.com/news/pronova-biopharma-to-foray-into-consumer-healthcare-market-111111/ 2011-11-11T05:13:00+00:00 https://www.pharmaceutical-business-review.com/news/bdsi-begins-study-on-buprenorphine-naloxone-111111/ 2011-11-11T05:27:00+00:00 https://www.pharmaceutical-business-review.com/news/vitrolife-parentplus-partner-to-develop-new-iui-products-111111/ 2011-11-11T05:36:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-advisory-committee-to-review-columbia-vaginal-gel-nda-111111/ 2011-11-11T06:20:00+00:00 https://www.pharmaceutical-business-review.com/news/dcgi-approves-intercell-biological-e-je-vaccine-111111/ 2011-11-11T06:29:00+00:00 https://www.pharmaceutical-business-review.com/news/modicare-releases-nutritional-drink-mix-for-kids-111111/ 2011-11-11T06:40:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-intelgenx-anti-depressant-drug-111111/ 2011-11-11T06:50:00+00:00 https://www.pharmaceutical-business-review.com/news/ablynx-alx-0081-proven-effective-in-acs-patients-111111/ 2011-11-11T07:27:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-signs-hiv-drug-technology-transfer-agreement-in-brazil-141111/ 2011-11-14T00:24:00+00:00 https://www.pharmaceutical-business-review.com/news/ampio-ampion-yields-positive-data-in-nasal-inflammation-treatment-141111/ 2011-11-14T00:28:00+00:00 https://www.pharmaceutical-business-review.com/news/adeona-to-assess-trimesta-drug-in-female-ms-patients-141111/ 2011-11-14T00:53:00+00:00 https://www.pharmaceutical-business-review.com/news/rop-biostructures-in-bone-remodeling-products-license-agreement-141111/ 2011-11-14T02:22:00+00:00 https://www.pharmaceutical-business-review.com/news/eliquis-drug-fails-to-meet-endpoint-in-phase-3-adopt-study-141111/ 2011-11-14T02:46:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-sends-crl-to-alimera-iluvien-nda-141111/ 2011-11-14T05:07:00+00:00 https://www.pharmaceutical-business-review.com/news/peginesatide-drug-treats-anemia-in-ckd-patients-141111/ 2011-11-14T05:30:00+00:00 https://www.pharmaceutical-business-review.com/news/genzyme-investigational-phase-iii-ms-drug-meets-co-primary-endpoints-141111/ 2011-11-14T05:35:00+00:00 https://www.pharmaceutical-business-review.com/news/cir-board-assigns-inci-name-to-proteoderm-new-anti-aging-skin-product-141111/ 2011-11-14T06:19:00+00:00 https://www.pharmaceutical-business-review.com/news/bend-merck-in-technology-license-agreement-141111/ 2011-11-14T06:28:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/us-researchers-develop-new-cancer-drug-screening-platform-141111/ 2011-11-14T06:42:00+00:00 https://www.pharmaceutical-business-review.com/news/concert-presents-ctp-499-drug-phase1-study-data-141111/ 2011-11-14T07:12:00+00:00 https://www.pharmaceutical-business-review.com/news/tetf-funds-leonardo-drug-delivery-technology-141111/ 2011-11-14T07:56:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-begins-rd-facility-construction-in-ridgefield-151111/ 2011-11-14T23:42:00+00:00 https://www.pharmaceutical-business-review.com/news/cspc-selects-manhattan-associates-warehouse-management-solution-151111/ 2011-11-14T23:59:00+00:00 https://www.pharmaceutical-business-review.com/news/theravance-reports-copd-drug-phase-2a-positive-results-151111/ 2011-11-15T02:01:00+00:00 https://www.pharmaceutical-business-review.com/news/horizon-pharma-third-quarter-net-loss-widens-151111/ 2011-11-15T02:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ajinomoto-launches-new-milk-protein-derived-supplement-151111/ 2011-11-15T02:32:00+00:00 https://www.pharmaceutical-business-review.com/news/qualitest-acetaminophen-codeine-phosphate-oral-solution-wins-fda-approval-151111/ 2011-11-15T03:38:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-to-review-neurogesx-s-nda-for-qutenza-151111/ 2011-11-15T03:52:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-pradaxa-reduces-stroke-risk-in-af-patients-re-ly-trial-151111/ 2011-11-15T04:06:00+00:00 https://www.pharmaceutical-business-review.com/news/ziopharm-reports-efficacy-of-palifosfamide-combination-therapy-against-sclc-151111/ 2011-11-15T04:16:00+00:00 https://www.pharmaceutical-business-review.com/news/lallemand-gm-pharmaceuticals-unveil-ismigen-in-georgia-151111/ 2011-11-15T04:25:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-uk-introduces-valsartan-hctz-generic-valsartan-151111/ 2011-11-15T05:22:00+00:00 https://www.pharmaceutical-business-review.com/news/invida-acquires-shalaks-dermatology-brand-products-151111/ 2011-11-15T05:25:00+00:00 https://www.pharmaceutical-business-review.com/news/anavex-completes-ad-drug-phase-1-sad-study-151111/ 2011-11-15T05:38:00+00:00 https://www.pharmaceutical-business-review.com/news/galenica-presents-injectafer-clinical-trials-data-151111/ 2011-11-15T05:49:00+00:00 https://www.pharmaceutical-business-review.com/news/biofocus-almirall-in-collaboration-agreement-151111/ 2011-11-15T06:58:00+00:00 https://www.pharmaceutical-business-review.com/news/profibrix-fibrocaps-phase-ii-study-meets-primary-endpoint-151111/ 2011-11-15T07:07:00+00:00 https://www.pharmaceutical-business-review.com/news/scil-proteins-completes-manufacturing-deal-with-lundbeck-151111/ 2011-11-15T07:13:00+00:00 https://www.pharmaceutical-business-review.com/news/simulations-plus-to-sell-words-subsidiary-to-prc-161111/ 2011-11-15T22:02:00+00:00 https://www.pharmaceutical-business-review.com/news/university-of-dundee-mmv-make-progress-in-antimalarial-research-161111/ 2011-11-15T22:52:00+00:00 https://www.pharmaceutical-business-review.com/news/canada-uk-join-forces-against-antibiotic-resistance-161111/ 2011-11-15T23:03:00+00:00 https://www.pharmaceutical-business-review.com/news/curevac-partners-with-sanofi-pasteur-to-develop-rnactive-platform-161111/ 2011-11-15T23:15:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-romania-to-invest-7m-in-brasov-plant-161111/ 2011-11-15T23:31:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-tibotec-to-develop-hiv-treatment-161111/ 2011-11-15T23:52:00+00:00 https://www.pharmaceutical-business-review.com/news/r-tech-ueno-selects-novozymes-biopharma-albucult-for-dry-eye-treatment-161111/ 2011-11-16T00:01:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-acceptable-status-to-intellipharma-toronto-manufacturing-facility-161111/ 2011-11-16T00:23:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-to-fund-university-of-rochester-to-develop-acute-chronic-pain-therapies-161111/ 2011-11-16T01:07:00+00:00 https://www.pharmaceutical-business-review.com/news/medgenics-epodure-shows-efficacy-in-anemia-treatment-161111/ 2011-11-16T01:10:00+00:00 https://www.pharmaceutical-business-review.com/news/barnabas-health-adopts-medaptus-management-automation-161111/ 2011-11-16T01:31:00+00:00 https://www.pharmaceutical-business-review.com/news/tcgls-jsw-in-strategic-alliance-161111/ 2011-11-16T04:58:00+00:00 https://www.pharmaceutical-business-review.com/news/revo-releases-tbolt-line-of-dietary-supplements-in-california-161111/ 2011-11-16T05:03:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-to-set-up-manufacturing-facility-in-saudi-arabia-161111/ 2011-11-16T05:17:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-perrigo-comfort-care-infant-formula-161111/ 2011-11-16T05:52:00+00:00 https://www.pharmaceutical-business-review.com/news/healthways-gsk-partner-for-otc-smoking-cessation-program-161111/ 2011-11-16T06:15:00+00:00 https://www.pharmaceutical-business-review.com/news/rnl-opens-stem-cell-medical-center-in-china-161111/ 2011-11-16T06:53:00+00:00 https://www.pharmaceutical-business-review.com/news/mvi-grants-additional-funds-to-profectus-biosciences-161111/ 2011-11-16T07:04:00+00:00 https://www.pharmaceutical-business-review.com/news/swissmedic-approves-monosol-midatech-to-initiate-pharmfilm-study-161111/ 2011-11-16T07:21:00+00:00 https://www.pharmaceutical-business-review.com/news/scientific-industries-to-expand-into-bioprocessing-products-market-161111/ 2011-11-16T07:22:00+00:00 https://www.pharmaceutical-business-review.com/news/corgenix-unveils-automated-ha-test-kit-171111/ 2011-11-16T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/georgia-tech-designs-new-software-for-drug-development-171111/ 2011-11-16T23:13:00+00:00 https://www.pharmaceutical-business-review.com/news/inc-researchsas-partner-for-clinical-trials-improvement-171111/ 2011-11-16T23:20:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-aileron-to-expand-collaboration-to-develop-stapled-peptide-drugs-171111/ 2011-11-16T23:57:00+00:00 https://www.pharmaceutical-business-review.com/news/genzyme-enters-research-agreement-with-cystic-fibrosis-171111/ 2011-11-17T00:07:00+00:00 https://www.pharmaceutical-business-review.com/news/onset-dermatologics-releases-hylatopicplus-cream-450-gram-jar-for-skin-repair-171111/ 2011-11-17T00:12:00+00:00 https://www.pharmaceutical-business-review.com/news/psychogenics-reaches-milestone-in-collaboration-with-roche-171111/ 2011-11-17T00:16:00+00:00 https://www.pharmaceutical-business-review.com/news/alnylam-grants-interferx-license-to-sylentis-171111/ 2011-11-17T01:52:00+00:00 https://www.pharmaceutical-business-review.com/news/cytodyn-inks-research-agreement-with-scripps-research-171111/ 2011-11-17T01:59:00+00:00 https://www.pharmaceutical-business-review.com/news/ampio-expands-patent-portfolio-of-anti-inflammatory-drugs-171111/ 2011-11-17T02:34:00+00:00 https://www.pharmaceutical-business-review.com/news/bionovo-to-initiate-menerba-dosing-in-phase-3-trial-171111/ 2011-11-17T02:44:00+00:00 https://www.pharmaceutical-business-review.com/news/ucb-enters-partnership-agreement-with-parexel-171111/ 2011-11-17T04:35:00+00:00 https://www.pharmaceutical-business-review.com/news/fujifilm-kyowa-hakko-kirin-to-develop-biosimilars-171111/ 2011-11-17T05:40:00+00:00 https://www.pharmaceutical-business-review.com/news/cenix-sygnis-in-research-collaboration-171111/ 2011-11-17T07:07:00+00:00 https://www.pharmaceutical-business-review.com/news/consumption-of-excess-vitamin-d-causes-atrial-fibrillation-us-study-171111/ 2011-11-17T07:10:00+00:00 https://www.pharmaceutical-business-review.com/news/ambit-names-michael-martino-as-new-ceo-171111/ 2011-11-17T07:17:00+00:00 https://www.pharmaceutical-business-review.com/news/polaris-to-set-up-anti-cancer-drug-manufacturing-plant-in-taiwan-171111/ 2011-11-17T07:21:00+00:00 https://www.pharmaceutical-business-review.com/news/hospira-introduces-imipenem-cilastatin-for-injection-iv-in-us-171111/ 2011-11-17T07:24:00+00:00 https://www.pharmaceutical-business-review.com/news/hsc-adopts-jac-medication-management-software-181111/ 2011-11-17T21:07:00+00:00 https://www.pharmaceutical-business-review.com/news/otsuka-chooses-cegedim-mobile-intelligence-saas-crm-solution-181111/ 2011-11-17T22:50:00+00:00 https://www.pharmaceutical-business-review.com/news/eu-approves-pfizer-vyndaqel-for-ttr-fap-181111/ 2011-11-17T23:54:00+00:00 https://www.pharmaceutical-business-review.com/news/vistagen-uhn-expand-stem-cell-research-and-development-program-181111/ 2011-11-18T00:00:00+00:00 https://www.pharmaceutical-business-review.com/news/marina-biotech-receives-chinese-patent-for-insulin-delivery-formulations-181111/ 2011-11-18T00:11:00+00:00 https://www.pharmaceutical-business-review.com/news/biothera-imprime-pgg-combination-therapy-shows-efficacy-against-cancer-181111/ 2011-11-18T00:18:00+00:00 https://www.pharmaceutical-business-review.com/news/chelsea-northera-drug-receives-fda-clearance-for-nda-filing-181111/ 2011-11-18T00:31:00+00:00 https://www.pharmaceutical-business-review.com/news/tesco-pharmacies-take-up-initiative-to-fight-dementia-181111/ 2011-11-18T02:22:00+00:00 https://www.pharmaceutical-business-review.com/news/vifor-pharma-cellcept-proven-superior-to-azathioprine-in-study-181111/ 2011-11-18T02:34:00+00:00 https://www.pharmaceutical-business-review.com/news/affymetrix-strikes-deal-with-genisphere-for-mirna-reagents-181111/ 2011-11-18T02:47:00+00:00 https://www.pharmaceutical-business-review.com/news/idri-receives-additional-funding-from-eli-lilly-to-combat-tb-181111/ 2011-11-18T04:07:00+00:00 https://www.pharmaceutical-business-review.com/news/shire-shionogi-to-co-develop-adhd-drugs-181111/ 2011-11-18T04:27:00+00:00 https://www.pharmaceutical-business-review.com/news/maryland-researchers-win-komen-grant-to-study-breast-treatment-complications-181111/ 2011-11-18T05:49:00+00:00 https://www.pharmaceutical-business-review.com/news/forte-joins-infoed-to-pre-integrate-systems-for-clinical-research-211111/ 2011-11-20T20:03:00+00:00 https://www.pharmaceutical-business-review.com/news/vitera-to-expand-cloud-based-vitera-intergy-on-demand-solution-211111/ 2011-11-20T23:08:00+00:00 https://www.pharmaceutical-business-review.com/news/gw-pharma-sativex-formulation-wins-epo-patent-181111/ 2011-11-20T23:34:00+00:00 https://www.pharmaceutical-business-review.com/news/merrimack-initiates-phase-2-trial-of-mm-121-with-erlotinib-211111/ 2011-11-21T00:20:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-caprelsa-earns-positive-chmp-opinion-for-mtc-211111/ 2011-11-21T00:24:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-novartis-enter-japan-co-promotion-agreement-for-copd-therapies-211111/ 2011-11-21T01:38:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-regeneron-eylea-injection-211111/ 2011-11-21T02:16:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-commencement-of-tonix-tnx-102-pkba-study-211111/ 2011-11-21T02:20:00+00:00 https://www.pharmaceutical-business-review.com/news/lupin-to-acquire-irom-pharma-211111/ 2011-11-21T04:13:00+00:00 https://www.pharmaceutical-business-review.com/news/valeant-to-acquire-inova-211111/ 2011-11-21T04:27:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-eusa-pharma-erwinaze-for-all-treatment-211111/ 2011-11-21T04:46:00+00:00 https://www.pharmaceutical-business-review.com/news/tasly-awards-phase-iii-t89-trial-to-icon-211111/ 2011-11-21T05:48:00+00:00 https://www.pharmaceutical-business-review.com/news/als-drug-trial-yields-positive-data-us-study-211111/ 2011-11-21T06:21:00+00:00 https://www.pharmaceutical-business-review.com/news/scripps-research-develops-new-class-of-molecules-for-drug-discovery-211111/ 2011-11-21T06:28:00+00:00 https://www.pharmaceutical-business-review.com/news/selecta-begins-sel-068-nicotine-vaccine-phase-1-trial-211111/ 2011-11-21T06:37:00+00:00 https://www.pharmaceutical-business-review.com/news/convergence-commences-phase-i-study-for-cnv2197944-211111/ 2011-11-21T06:47:00+00:00 https://www.pharmaceutical-business-review.com/news/biopharm-introduces-siebel-clinical-process-reengineering-service-221111/ 2011-11-21T21:00:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-to-acquire-pharmasset-for-11bn-211111/ 2011-11-21T23:42:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-mit-to-open-new-research-units-in-massachusetts-211111/ 2011-11-21T23:49:00+00:00 https://www.pharmaceutical-business-review.com/news/exelixis-to-start-cabozantinib-phase-2-ist-study-211111/ 2011-11-22T00:34:00+00:00 https://www.pharmaceutical-business-review.com/news/rising-pharma-introduces-generic-version-of-ancobon-capsules-aralen-tablets-221111/ 2011-11-22T00:40:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-wins-ema-approval-for-regulatory-submission-of-tofacitinib-221111/ 2011-11-22T00:49:00+00:00 https://www.pharmaceutical-business-review.com/news/portola-receives-89m-to-begin-betrixaban-phase-3-study-221111/ 2011-11-22T01:14:00+00:00 https://www.pharmaceutical-business-review.com/news/celldex-rindopepimut-vaccine-trial-yields-positive-data-221111/ 2011-11-22T01:21:00+00:00 https://www.pharmaceutical-business-review.com/news/eco-vita-releases-new-tea-for-skin-detoxification-221111/ 2011-11-22T02:16:00+00:00 https://www.pharmaceutical-business-review.com/news/aut-investigates-pine-bark-supplements-for-tbi-treatment-221111/ 2011-11-22T02:23:00+00:00 https://www.pharmaceutical-business-review.com/news/amneal-introduces-topical-fluocinolone-acetonide-oil-line-of-products-221111/ 2011-11-22T05:10:00+00:00 https://www.pharmaceutical-business-review.com/news/healogix-appoints-tim-edbrooke-as-new-president-221111/ 2011-11-22T05:19:00+00:00 https://www.pharmaceutical-business-review.com/news/swissmedic-approves-celgene-revlimid-to-treat-rare-blood-cancer-221111/ 2011-11-22T05:26:00+00:00 https://www.pharmaceutical-business-review.com/news/omega-3-fatty-acids-protect-diabetics-with-previous-heart-attack-study-221111/ 2011-11-22T05:40:00+00:00 https://www.pharmaceutical-business-review.com/news/ferring-to-set-up-new-facility-in-us-221111/ 2011-11-22T05:47:00+00:00 https://www.pharmaceutical-business-review.com/news/adeona-intrexon-ink-deal-for-dna-based-therapy-in-pah-treatment-221111/ 2011-11-22T05:55:00+00:00 https://www.pharmaceutical-business-review.com/news/novavax-acquires-two-manufacturing-facilities-221111/ 2011-11-22T06:13:00+00:00 https://www.pharmaceutical-business-review.com/news/galapagos-glpg0634-phase-ii-study-meets-primary-endpoint-221111/ 2011-11-22T06:20:00+00:00 https://www.pharmaceutical-business-review.com/news/dmc-recommends-celgene-to-discontinue-phase-iii-mainsail-trial-241111/ 2011-11-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/andromeda-presents-t1d-drug-initial-phase-iii-trial-results-241111/ 2011-11-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-wins-us-patent-for-enbrel-241111/ 2011-11-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/harborview-medical-center-inks-trial-deal-with-daxor-231111/ 2011-11-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/harborview-medical-center-enters-into-trial-agreement-with-daxor-231111/ 2011-11-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/biolinerx-wins-indian-regulatory-approval-to-begin-clarity-phase-iiiii-trial-231111/ 2011-11-22T23:43:00+00:00 https://www.pharmaceutical-business-review.com/news/amarantus-biosciences-banyan-biomarkers-enter-research-collaboration-deal-231111/ 2011-11-22T23:49:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-astrazeneca-uk-agency-to-develop-cancer-treatment-231111/ 2011-11-22T23:54:00+00:00 https://www.pharmaceutical-business-review.com/news/abq-health-partners-adopts-aternity-fpi-platform-231111/ 2011-11-22T23:59:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-to-acquire-excaliard-231111/ 2011-11-23T00:15:00+00:00 https://www.pharmaceutical-business-review.com/news/prana-earns-approval-to-begin-alzheimers-drug-trial-231111/ 2011-11-23T02:36:00+00:00 https://www.pharmaceutical-business-review.com/news/biofactura-secures-us-patent-for-stablefast-biomanufacturing-platform-231111/ 2011-11-23T02:40:00+00:00 https://www.pharmaceutical-business-review.com/news/octoplus-secures-drug-manufacturing-contract-231111/ 2011-11-23T02:47:00+00:00 https://www.pharmaceutical-business-review.com/news/tjoapack-acquires-prolepha-231111/ 2011-11-23T02:54:00+00:00 https://www.pharmaceutical-business-review.com/news/cara-begins-oral-opioid-agonist-first-in-man-phase-i-clinical-trial-231111/ 2011-11-23T04:53:00+00:00 https://www.pharmaceutical-business-review.com/news/ucb-takes-over-lectus-key-pharmaceutical-assets-231111/ 2011-11-23T05:00:00+00:00 https://www.pharmaceutical-business-review.com/news/altacor-partner-proximagen-to-advance-5ht2c-programme-in-glaucoma-231111/ 2011-11-23T06:38:00+00:00 https://www.pharmaceutical-business-review.com/news/pivotal-introduces-vascazen-in-north-america-231111/ 2011-11-23T06:42:00+00:00 https://www.pharmaceutical-business-review.com/news/psivida-to-evaluate-drug-delivery-technology-231111/ 2011-11-23T06:47:00+00:00 https://www.pharmaceutical-business-review.com/news/embria-epicor-completes-fda-ndi-process-231111/ 2011-11-23T06:49:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-review-of-regeneron-arcalyst-sbla-231111/ 2011-11-23T06:56:00+00:00 https://www.pharmaceutical-business-review.com/news/shire-submits-regulatory-filings-with-eu-fda-for-vpriv-production-231111/ 2011-11-23T07:01:00+00:00 https://www.pharmaceutical-business-review.com/news/bd-diagnostics-hai-assay-earns-ce-mark-241111/ 2011-11-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/transcept-insomnia-drug-receives-fda-approval-241111/ 2011-11-23T23:50:00+00:00 https://www.pharmaceutical-business-review.com/news/compressus-selects-ibm-software-241111/ 2011-11-24T00:07:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-submits-nda-for-type-2-diabetes-combination-therapy-241111/ 2011-11-24T00:17:00+00:00 https://www.pharmaceutical-business-review.com/news/aeterna-zentaris-inks-licensing-deal-with-hikma-for-perifosine-in-mena-241111/ 2011-11-24T00:22:00+00:00 https://www.pharmaceutical-business-review.com/news/cannabis-introduces-second-cannabis-extract-based-formulation-241111/ 2011-11-24T00:26:00+00:00 https://www.pharmaceutical-business-review.com/news/horizon-discovery-nih-enter-research-collaboration-241111/ 2011-11-24T02:15:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-frqs-innovation-fund-selects-hiv-skin-cancer-research-projects-241111/ 2011-11-24T02:28:00+00:00 https://www.pharmaceutical-business-review.com/news/us-researchers-devise-new-method-to-support-antipsychotic-drug-development-241111/ 2011-11-24T02:33:00+00:00 https://www.pharmaceutical-business-review.com/news/puma-biotechnology-completes-second-round-financing-241111/ 2011-11-24T02:40:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-spectrum-to-remove-bioscan-for-zevalin-treatment-241111/ 2011-11-24T02:48:00+00:00 https://www.pharmaceutical-business-review.com/news/sohm-acquires-business-brands-of-novatrend-241111/ 2011-11-24T04:37:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-status-to-summit-smt-c1100-241111/ 2011-11-24T05:44:00+00:00 https://www.pharmaceutical-business-review.com/news/l-arginine-does-not-benefit-fit-athletic-men-study-241111/ 2011-11-24T06:53:00+00:00 https://www.pharmaceutical-business-review.com/news/prometic-octaplaslg-receives-confirmation-of-approval-in-more-eu-nations-241111/ 2011-11-24T07:00:00+00:00 https://www.pharmaceutical-business-review.com/news/ideal-cures-releases-new-film-coating-materials-241111/ 2011-11-24T07:02:00+00:00 https://www.pharmaceutical-business-review.com/news/instantgmp-unveils-new-web-page-on-gmp-251111/ 2011-11-24T21:14:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmaleads-pl37-yields-positive-data-251111/ 2011-11-24T23:56:00+00:00 https://www.pharmaceutical-business-review.com/news/cipher-submits-nda-amendment-for-cip-isotretinoin-to-fda-251111/ 2011-11-25T00:08:00+00:00 https://www.pharmaceutical-business-review.com/news/radius-completes-second-tranche-of-financing-251111/ 2011-11-25T01:35:00+00:00 https://www.pharmaceutical-business-review.com/news/stempeutics-to-introduce-new-stem-cell-products-251111/ 2011-11-25T01:54:00+00:00 https://www.pharmaceutical-business-review.com/news/ucb-opts-out-of-biotie-syn118-licensing-option-251111/ 2011-11-25T02:14:00+00:00 https://www.pharmaceutical-business-review.com/news/transgene-biotek-to-sell-rh-epo-technology-to-tss-251111/ 2011-11-25T02:48:00+00:00 https://www.pharmaceutical-business-review.com/news/shire-to-demonstrate-bioasis-transcend-technology-251111/ 2011-11-25T02:56:00+00:00 https://www.pharmaceutical-business-review.com/news/bellwyck-takes-over-ace-packaging-251111/ 2011-11-25T04:10:00+00:00 https://www.pharmaceutical-business-review.com/news/randox-plans-to-launch-new-immunoassay-solution-251111/ 2011-11-25T04:56:00+00:00 https://www.pharmaceutical-business-review.com/news/essilor-names-hubert-sagnieres-as-new-chairman-251111/ 2011-11-25T05:17:00+00:00 https://www.pharmaceutical-business-review.com/news/chugai-to-adopt-ipad2-as-a-tool-for-mrs-mas-281111/ 2011-11-27T23:15:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-invests-271m-in-new-rd-center-in-switzerland-281111/ 2011-11-27T23:40:00+00:00 https://www.pharmaceutical-business-review.com/news/synairgen-pneumonia-therapy-yields-positive-data-281111/ 2011-11-27T23:48:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmaust-raises-stake-to-51-in-jv-with-curtin-university-281111/ 2011-11-28T00:39:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-amarin-nda-for-amr101-drug-281111/ 2011-11-28T00:52:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-sues-dietary-supplement-maker-for-violating-laws-281111/ 2011-11-28T02:32:00+00:00 https://www.pharmaceutical-business-review.com/news/hanmi-applies-for-orphan-drug-designation-for-laps-rhgh-281111/ 2011-11-28T02:36:00+00:00 https://www.pharmaceutical-business-review.com/news/swedish-agency-grants-approval-for-immunicum-cancer-vaccine-trial-281111/ 2011-11-28T02:43:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-registers-copd-drug-nda-in-japan-281111/ 2011-11-28T04:51:00+00:00 https://www.pharmaceutical-business-review.com/news/university-of-cambridge-elan-enter-collaboration-deal-281111/ 2011-11-28T05:01:00+00:00 https://www.pharmaceutical-business-review.com/news/nicox-completes-patient-enrollment-for-bol-303259-x-phase-2b-study-281111/ 2011-11-28T05:15:00+00:00 https://www.pharmaceutical-business-review.com/news/university-of-oxford-progenra-present-data-on-anti-tumor-compound-281111/ 2011-11-28T05:24:00+00:00 https://www.pharmaceutical-business-review.com/news/gvk-bio-moulder-center-in-drug-discovery-alliance-281111/ 2011-11-28T05:35:00+00:00 https://www.pharmaceutical-business-review.com/news/moleac-introduces-nuraid-ii-in-france-281111/ 2011-11-28T06:28:00+00:00 https://www.pharmaceutical-business-review.com/news/revhoney-to-add-new-flavor-to-energy-drink-line-281111/ 2011-11-28T06:46:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-bgi-devise-mhc-region-capture-technology-291111/ 2011-11-28T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/northern-california-surgery-center-adopts-provation-ehr-software-291111/ 2011-11-28T23:16:00+00:00 https://www.pharmaceutical-business-review.com/news/allergy-therapeutics-submits-response-on-maa-to-pei-in-germany-291111/ 2011-11-29T00:01:00+00:00 https://www.pharmaceutical-business-review.com/news/onglyza-earns-european-approval-for-type-2-diabetes-treatment-291111/ 2011-11-29T00:06:00+00:00 https://www.pharmaceutical-business-review.com/news/provepharm-martindale-to-supply-proveblue-for-injection-in-uk-ireland-291111/ 2011-11-29T00:11:00+00:00 https://www.pharmaceutical-business-review.com/news/edge-funds-development-of-heparinex-drug-delivery-technology-291111/ 2011-11-29T02:20:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-high-blood-pressure-drug-wins-european-approval-291111/ 2011-11-29T02:24:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-approval-for-biomarin-facility-expansion-291111/ 2011-11-29T03:48:00+00:00 https://www.pharmaceutical-business-review.com/news/inspiration-biopharmaceuticals-begins-second-phase-iii-trial-of-obi-1-291111/ 2011-11-29T04:35:00+00:00 https://www.pharmaceutical-business-review.com/news/micromet-begins-blinatumomab-phase-2-trial-291111/ 2011-11-29T04:37:00+00:00 https://www.pharmaceutical-business-review.com/news/sri-lanka-to-take-up-drug-manufacturing-program-291111/ 2011-11-29T05:47:00+00:00 https://www.pharmaceutical-business-review.com/news/biologics-modular-initiates-manufacturing-facilities-leasing-program-291111/ 2011-11-29T05:51:00+00:00 https://www.pharmaceutical-business-review.com/news/university-of-texas-to-set-up-cancer-drug-development-center-291111/ 2011-11-29T06:47:00+00:00 https://www.pharmaceutical-business-review.com/news/eu-grants-marketing-authorization-to-gilead-for-hiv-1-drug-291111/ 2011-11-29T06:52:00+00:00 https://www.pharmaceutical-business-review.com/news/regeneron-bayer-commence-phase-3-trial-of-eylea-injection-291111/ 2011-11-29T06:59:00+00:00 https://www.pharmaceutical-business-review.com/news/exelixis-signs-crada-with-nci-ctep-for-cabozantinib-291111/ 2011-11-29T07:10:00+00:00 https://www.pharmaceutical-business-review.com/news/wake-forest-selects-huron-ctms-to-automate-clinical-trials-301111/ 2011-11-29T20:24:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-lodotra-nda-review-301111/ 2011-11-29T23:48:00+00:00 https://www.pharmaceutical-business-review.com/news/infinity-mundipharma-expand-drug-development-collaboration-301111/ 2011-11-29T23:55:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-hiv-drug-earns-european-approval-301111/ 2011-11-30T00:04:00+00:00 https://www.pharmaceutical-business-review.com/news/paladin-inks-marketing-deal-for-travelan-301111/ 2011-11-30T01:44:00+00:00 https://www.pharmaceutical-business-review.com/news/biomarin-begins-phase-2-study-for-galns-301111/ 2011-11-30T01:49:00+00:00 https://www.pharmaceutical-business-review.com/news/elan-sings-manufacturing-deal-with-lonza-for-elnd005-ingredient-301111/ 2011-11-30T02:01:00+00:00 https://www.pharmaceutical-business-review.com/news/ms-society-of-canada-to-fund-multiple-sclerosis-study-301111/ 2011-11-30T03:51:00+00:00 https://www.pharmaceutical-business-review.com/news/leonardo-nma-ink-deal-for-production-of-nanoparticles-301111/ 2011-11-30T04:15:00+00:00 https://www.pharmaceutical-business-review.com/news/cuba-to-combat-cancer-with-new-biotechnological-branch-301111/ 2011-11-30T04:20:00+00:00 https://www.pharmaceutical-business-review.com/news/nai-secures-new-us-patent-for-beta-alanine-301111/ 2011-11-30T04:25:00+00:00 https://www.pharmaceutical-business-review.com/news/omthera-enrolls-patients-for-phase-iii-evolve-trial-301111/ 2011-11-30T06:11:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-watson-vestura-anda-301111/ 2011-11-30T07:00:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-grants-patent-to-antares-pharma-libigel-301111/ 2011-11-30T07:06:00+00:00 https://www.pharmaceutical-business-review.com/news/komboglyze-for-type-2-diabetes-earns-european-clearance-301111/ 2011-11-30T07:19:00+00:00 https://www.pharmaceutical-business-review.com/news/medunik-canada-to-market-new-therapies-for-rare-diseases-301111/ 2011-11-30T07:36:00+00:00 https://www.pharmaceutical-business-review.com/news/uk-based-burkert-opens-new-mobile-customer-specific-clinics-301111/ 2011-11-30T07:41:00+00:00 https://www.pharmaceutical-business-review.com/news/cognizant-to-provide-biostatistics-medical-reporting-services-for-astrazeneca-011211/ 2011-11-30T23:13:00+00:00 https://www.pharmaceutical-business-review.com/news/onconova-adopts-bioclinica-express-011211/ 2011-11-30T23:43:00+00:00 https://www.pharmaceutical-business-review.com/news/idera-regains-imo-2055-rights-from-merck-kgaa-011211/ 2011-11-30T23:57:00+00:00 https://www.pharmaceutical-business-review.com/news/watson-introduces-generic-version-of-lipitor-011211/ 2011-12-01T00:01:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-introduces-warfarin-granules-02-in-japan-011211/ 2011-12-01T01:50:00+00:00 https://www.pharmaceutical-business-review.com/news/prometic-plasma-derived-products-collaboration-with-cnbg-reaches-key-milestone-011211/ 2011-12-01T01:55:00+00:00 https://www.pharmaceutical-business-review.com/news/merrimack-initiates-dosing-in-mm-121-phase-1-study-011211/ 2011-12-01T01:57:00+00:00 https://www.pharmaceutical-business-review.com/news/atmi-unveils-new-bioreactor-systems-for-cell-based-products-011211/ 2011-12-01T02:00:00+00:00 https://www.pharmaceutical-business-review.com/news/swedish-council-offers-research-grant-to-orexo-uppsala-university-011211/ 2011-12-01T04:50:00+00:00 https://www.pharmaceutical-business-review.com/news/bioseek-reaches-drug-discovery-research-milestone-011211/ 2011-12-01T04:58:00+00:00 https://www.pharmaceutical-business-review.com/news/cannabis-releases-extract-based-formulations-011211/ 2011-12-01T05:08:00+00:00 https://www.pharmaceutical-business-review.com/news/conditas-synthesis-med-chem-ink-drug-discovery-deal-011211/ 2011-12-01T05:21:00+00:00 https://www.pharmaceutical-business-review.com/news/european-parliament-launches-pain-alliance-europe-011211/ 2011-12-01T05:24:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-grants-patent-to-nephrx-nx002-011211/ 2011-12-01T05:27:00+00:00 https://www.pharmaceutical-business-review.com/news/safecor-health-expands-contract-with-novation-011211/ 2011-12-01T07:06:00+00:00 https://www.pharmaceutical-business-review.com/news/cytokinetics-ck-2017357-drug-yields-positive-data-011211/ 2011-12-01T07:10:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-takes-over-ferrosan-consumer-health-business-011211/ 2011-12-01T07:16:00+00:00 https://www.pharmaceutical-business-review.com/news/actelion-adopts-veeva-solutions-globally-021211/ 2011-12-01T19:56:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-aveo-strike-ficlatuzumab-manufacturing-deal-021211/ 2011-12-01T23:58:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-commences-drug-development-operations-at-us-facility-021211/ 2011-12-02T00:14:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-idera-psoriasis-therapy-trial-021211/ 2011-12-02T01:33:00+00:00 https://www.pharmaceutical-business-review.com/news/thomson-reuters-secures-mjff-grant-to-create-parkinsons-biological-maps-021211/ 2011-12-02T01:40:00+00:00 https://www.pharmaceutical-business-review.com/news/santarus-uceris-shows-promising-data-in-ulcerative-colitis-021211/ 2011-12-02T01:48:00+00:00 https://www.pharmaceutical-business-review.com/news/atheronova-maxwell-ratify-atherosclerosis-drug-development-deal-021211/ 2011-12-02T06:11:00+00:00 https://www.pharmaceutical-business-review.com/news/oso-energy-beverage-goes-all-natural-021211/ 2011-12-02T06:18:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-sues-syntec-dietary-supplements-for-false-claims-021211/ 2011-12-02T06:21:00+00:00 https://www.pharmaceutical-business-review.com/news/cardinal-health-to-launch-new-packaging-solutions-for-oral-liquid-medications-021211/ 2011-12-02T06:35:00+00:00 https://www.pharmaceutical-business-review.com/news/nps-submits-nda-for-sbs-drug-021211/ 2011-12-02T06:37:00+00:00 https://www.pharmaceutical-business-review.com/news/auxilium-initiates-dosing-in-phase-iia-trial-of-xiaflex-021211/ 2011-12-02T06:41:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-designation-for-emergent-tru-016-021211/ 2011-12-02T06:48:00+00:00 https://www.pharmaceutical-business-review.com/news/diamedica-announces-encouraging-type-2-diabetes-data-021211/ 2011-12-02T06:52:00+00:00 https://www.pharmaceutical-business-review.com/news/amicus-begins-pompe-disease-drug-phase-2-study-021211/ 2011-12-02T06:55:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-atorvastatin-calcium-tablets-anda-wins-fda-tentative-approval-021211/ 2011-12-02T07:02:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-inks-research-deal-with-tibotec-for-daclatasvir-051211/ 2011-12-05T00:30:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-receives-final-fda-approval-for-tranexamic-acid-injection-051211/ 2011-12-05T00:37:00+00:00 https://www.pharmaceutical-business-review.com/news/metro-spinal-clinic-adopts-ibm-software-051211/ 2011-12-05T00:42:00+00:00 https://www.pharmaceutical-business-review.com/news/trimel-receives-gmp-compliance-designation-from-health-canada-051211/ 2011-12-05T01:40:00+00:00 https://www.pharmaceutical-business-review.com/news/svetol-shows-efficacy-in-weight-loss-051211/ 2011-12-05T02:21:00+00:00 https://www.pharmaceutical-business-review.com/news/the-institute-for-vibrant-living-unveils-new-digestive-supplement-051211/ 2011-12-05T02:24:00+00:00 https://www.pharmaceutical-business-review.com/news/zealand-reports-positive-results-on-type-2-diabetes-drug-051211/ 2011-12-05T02:39:00+00:00 https://www.pharmaceutical-business-review.com/news/formula-to-raise-financing-for-leukemia-vaccine-phase-ii-trials-051211/ 2011-12-05T02:57:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-regeneron-report-encouraging-data-from-phase-3-amd-studies-051211/ 2011-12-05T03:52:00+00:00 https://www.pharmaceutical-business-review.com/news/kyowa-hakko-kirin-launches-nauzelin-od-tablet-formulation-051211/ 2011-12-05T05:01:00+00:00 https://www.pharmaceutical-business-review.com/news/lancaster-bioazure-join-forces-for-development-of-indian-biotech-products-051211/ 2011-12-05T05:05:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-acquires-excaliard-051211/ 2011-12-05T05:12:00+00:00 https://www.pharmaceutical-business-review.com/news/tanzania-to-set-up-generic-arvs-manufacturing-plant-051211/ 2011-12-05T05:17:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-romania-invests-7m-in-brasov-plant-051211/ 2011-12-05T06:15:00+00:00 https://www.pharmaceutical-business-review.com/news/futura-medical-introduces-new-cellulite-treatment-051211/ 2011-12-05T06:21:00+00:00 https://www.pharmaceutical-business-review.com/news/fds-pharma-acquires-scigen-israel-hepatitis-vaccine-manufacturing-plant-051211/ 2011-12-05T07:02:00+00:00 https://www.pharmaceutical-business-review.com/news/mckesson-unveils-new-automation-solutions-for-health-care-systems-061211/ 2011-12-05T21:16:00+00:00 https://www.pharmaceutical-business-review.com/news/talyst-introduces-new-automated-storage-pharmacy-grade-refrigeration-system-061211/ 2011-12-05T23:08:00+00:00 https://www.pharmaceutical-business-review.com/news/achillion-reports-phase-1b-results-of-hcv-drug-061211/ 2011-12-05T23:37:00+00:00 https://www.pharmaceutical-business-review.com/news/biogen-idec-samsung-form-jv-to-manufacture-biosimilars-061211/ 2011-12-05T23:45:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-announces-efficacy-data-of-toviaz-061211/ 2011-12-05T23:49:00+00:00 https://www.pharmaceutical-business-review.com/news/ampio-to-acquire-drug-delivery-technology-for-marketing-zertane-odt-061211/ 2011-12-06T02:33:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-cobicistat-shows-efficacy-in-phase-3-study-061211/ 2011-12-06T02:37:00+00:00 https://www.pharmaceutical-business-review.com/news/nipro-to-invest-in-jmi-pharma-in-bangladesh-061211/ 2011-12-06T04:42:00+00:00 https://www.pharmaceutical-business-review.com/news/health-canada-issues-product-license-for-pivotal-omazen-061211/ 2011-12-06T04:46:00+00:00 https://www.pharmaceutical-business-review.com/news/green-tea-reduces-cholesterol-us-study-061211/ 2011-12-06T04:51:00+00:00 https://www.pharmaceutical-business-review.com/news/herbalife-starts-operations-in-ghana-061211/ 2011-12-06T04:55:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-to-establish-new-vaccine-business-division-061211/ 2011-12-06T05:16:00+00:00 https://www.pharmaceutical-business-review.com/news/arjohuntleigh-introduces-new-division-for-home-medical-care-061211/ 2011-12-06T05:23:00+00:00 https://www.pharmaceutical-business-review.com/news/ovagene-signs-licensing-agreement-with-moffitt-cancer-center-061211/ 2011-12-06T06:53:00+00:00 https://www.pharmaceutical-business-review.com/news/technology-and-innovation-centre-in-cell-therapy-to-receive-50m-funding-061211/ 2011-12-06T07:12:00+00:00 https://www.pharmaceutical-business-review.com/news/malvern-and-novozymes-evaluate-formulation-stability-of-recombinant-albumins-061211/ 2011-12-06T07:21:00+00:00 https://www.pharmaceutical-business-review.com/news/marken-unveils-new-solution-for-clinical-trials-management-071211/ 2011-12-06T18:54:00+00:00 https://www.pharmaceutical-business-review.com/news/acetylon-choses-sidera-for-internet-infrastructure-071211/ 2011-12-07T00:02:00+00:00 https://www.pharmaceutical-business-review.com/news/peregrine-says-bavituximab-combination-therapy-treats-lung-cancer-071211/ 2011-12-07T00:49:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-galvus-earns-european-approval-071211/ 2011-12-07T00:53:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-reports-positive-results-of-lixisenatide-combination-therapy-071211/ 2011-12-07T01:54:00+00:00 https://www.pharmaceutical-business-review.com/news/allergy-therapeutics-to-launch-anapen-in-uk-ireland-071211/ 2011-12-07T02:09:00+00:00 https://www.pharmaceutical-business-review.com/news/ranbaxy-launches-generic-version-of-caduet-in-us-071211/ 2011-12-07T02:17:00+00:00 https://www.pharmaceutical-business-review.com/news/discovery-afectair-found-to-improve-nitric-oxide-delivery-071211/ 2011-12-07T02:24:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-to-set-up-new-rd-center-in-china-071211/ 2011-12-07T02:36:00+00:00 https://www.pharmaceutical-business-review.com/news/genvec-novartis-collaboration-reaches-second-milestone-071211/ 2011-12-07T03:49:00+00:00 https://www.pharmaceutical-business-review.com/news/altrient-to-release-new-supplements-with-led-system-071211/ 2011-12-07T05:50:00+00:00 https://www.pharmaceutical-business-review.com/news/numerate-boehringer-ink-research-collaboration-deal-071211/ 2011-12-07T05:54:00+00:00 https://www.pharmaceutical-business-review.com/news/pbr-launches-pharmaceutical-industry-survey-071211/ 2011-12-07T06:35:00+00:00 https://www.pharmaceutical-business-review.com/news/imcd-to-acquire-organotec-fine-chemicals-business-in-italy-071211/ 2011-12-07T07:22:00+00:00 https://www.pharmaceutical-business-review.com/news/almac-and-beactica-sing-drug-discovery-agreement-071211/ 2011-12-07T07:25:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-and-ftc-to-remove-hcg-weight-loss-products-from-market-071211/ 2011-12-07T07:28:00+00:00 https://www.pharmaceutical-business-review.com/news/cegedim-introduces-new-solution-rems-081211/ 2011-12-07T20:40:00+00:00 https://www.pharmaceutical-business-review.com/news/viropharma-and-halozyme-announce-positive-data-from-hae-study-071211/ 2011-12-07T23:40:00+00:00 https://www.pharmaceutical-business-review.com/news/ziopharm-receives-european-patent-for-palifosfamide-081211/ 2011-12-07T23:46:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-breast-cancer-drug-shows-promising-data-081211/ 2011-12-07T23:55:00+00:00 https://www.pharmaceutical-business-review.com/news/watson-introduces-generic-loseasonique-081211/ 2011-12-08T00:05:00+00:00 https://www.pharmaceutical-business-review.com/news/avedro-wins-fda-orphan-drug-status-for-vibex-solution-081211/ 2011-12-08T01:54:00+00:00 https://www.pharmaceutical-business-review.com/news/bosch-introduces-new-technologies-for-pharmaceutical-production-process-081211/ 2011-12-08T02:23:00+00:00 https://www.pharmaceutical-business-review.com/news/aradigm-earns-us-patent-for-pulmaquin-081211/ 2011-12-08T02:30:00+00:00 https://www.pharmaceutical-business-review.com/news/genentech-pertuzumab-to-treat-her2-positive-metastatic-breast-cancer-081211/ 2011-12-08T03:32:00+00:00 https://www.pharmaceutical-business-review.com/news/vistagen-enters-strategic-medicinal-chemistry-deal-with-synterys-081211/ 2011-12-08T03:35:00+00:00 https://www.pharmaceutical-business-review.com/news/indian-drug-manufacturing-facility-earns-european-cgmp-approval-081211/ 2011-12-08T03:49:00+00:00 https://www.pharmaceutical-business-review.com/news/amarin-initiates-cardiovascular-outcomes-study-reduce-it-081211/ 2011-12-08T06:31:00+00:00 https://www.pharmaceutical-business-review.com/news/melanplus-releases-new-gray-hair-vitamins-081211/ 2011-12-08T06:35:00+00:00 https://www.pharmaceutical-business-review.com/news/norgine-and-tranzyme-complete-patient-enrollment-in-phase-3-ulimorelin-trial-081211/ 2011-12-08T06:39:00+00:00 https://www.pharmaceutical-business-review.com/news/pycnogenol-supplementation-improves-cognitive-function-081211/ 2011-12-08T06:46:00+00:00 https://www.pharmaceutical-business-review.com/news/molecular-partners-janssen-to-jointly-develop-darpins-081211/ 2011-12-08T07:02:00+00:00 https://www.pharmaceutical-business-review.com/news/ge-microsoft-to-form-healthcare-system-transformation-jv-091211/ 2011-12-08T23:21:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-to-acquire-chinese-generics-company-091211/ 2011-12-09T00:18:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-biotech-joins-pharmacyclics-for-anti-cancer-drug-development-091211/ 2011-12-09T00:33:00+00:00 https://www.pharmaceutical-business-review.com/news/biochemics-announces-positive-phase-2-data-for-osteoarthritis-drug-081211/ 2011-12-09T01:42:00+00:00 https://www.pharmaceutical-business-review.com/news/pearl-reports-positive-top-line-results-from-phase-2b-copd-study-091211/ 2011-12-09T01:46:00+00:00 https://www.pharmaceutical-business-review.com/news/enzon-peg-sn38-drug-shows-efficacy-against-breast-cancer-091211/ 2011-12-09T01:49:00+00:00 https://www.pharmaceutical-business-review.com/news/biorestorative-university-of-utah-enter-manufacturing-deal-091211/ 2011-12-09T01:53:00+00:00 https://www.pharmaceutical-business-review.com/news/natures-bioceuticals-develops-new-prostate-formula-091211/ 2011-12-09T01:57:00+00:00 https://www.pharmaceutical-business-review.com/news/nanobio-merck-enter-research-collaboration-for-rsv-vaccine-091211/ 2011-12-09T03:41:00+00:00 https://www.pharmaceutical-business-review.com/news/raintree-oncology-signs-service-deal-with-diplomat-091211/ 2011-12-09T04:47:00+00:00 https://www.pharmaceutical-business-review.com/news/herbalife-introduces-herbal-energy-drink-in-india-091211/ 2011-12-09T04:56:00+00:00 https://www.pharmaceutical-business-review.com/news/meda-collaborates-with-omega-for-sb12-091211/ 2011-12-09T05:52:00+00:00 https://www.pharmaceutical-business-review.com/news/moberg-sign-new-distribution-agreement-for-emtrix-in-italy-091211/ 2011-12-09T05:57:00+00:00 https://www.pharmaceutical-business-review.com/news/igi-signs-strategic-partnership-with-medimetriks-091211/ 2011-12-09T06:04:00+00:00 https://www.pharmaceutical-business-review.com/news/metabolex-reports-efficacy-results-of-arhalofenate-combination-therapy-091211/ 2011-12-09T06:09:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-launches-generic-anti-obesity-drug-091211/ 2011-12-09T06:12:00+00:00 https://www.pharmaceutical-business-review.com/news/rosetta-microrna-based-test-earns-doh-approval-121211/ 2011-12-11T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/signal-genetics-to-release-myprs-plus-121611/ 2011-12-11T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ibm-gives-chemical-data-to-nih-for-drug-discovery-and-cancer-research-121211/ 2011-12-11T20:00:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-hiv-therapy-trial-meets-end-point-121211/ 2011-12-12T00:03:00+00:00 https://www.pharmaceutical-business-review.com/news/vertex-alios-biopharma-commence-studies-for-hepatitis-c-treatment-121211/ 2011-12-12T00:06:00+00:00 https://www.pharmaceutical-business-review.com/news/ezose-sciences-merck-enter-deal-for-biomarker-discovery-in-diabetes-121211/ 2011-12-12T00:11:00+00:00 https://www.pharmaceutical-business-review.com/news/sihuan-to-open-new-production-and-rd-plant-in-beijing-121211/ 2011-12-12T01:28:00+00:00 https://www.pharmaceutical-business-review.com/news/semler-plans-asian-expansion-with-aca-121211/ 2011-12-12T01:32:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-onyx-nda-for-carfilzomib-in-myeloma-treatment-121211/ 2011-12-12T01:34:00+00:00 https://www.pharmaceutical-business-review.com/news/sanner-on-expansion-spree-in-asia-121211/ 2011-12-12T04:20:00+00:00 https://www.pharmaceutical-business-review.com/news/taigen-acquires-global-rights-for-nemonoxacin-121211/ 2011-12-12T04:23:00+00:00 https://www.pharmaceutical-business-review.com/news/clarient-acorn-strike-research-deal-for-molecular-tumor-tests-121211/ 2011-12-12T05:30:00+00:00 https://www.pharmaceutical-business-review.com/news/genmab-reports-daratumumab-preliminary-data-in-multiple-myeloma-121211/ 2011-12-12T05:38:00+00:00 https://www.pharmaceutical-business-review.com/news/pharming-receives-us-patent-for-recombinant-c1-inhibitor-121211/ 2011-12-12T05:42:00+00:00 https://www.pharmaceutical-business-review.com/news/molecularmd-receives-patent-for-detecting-drug-resistant-egfr-mutant-121211/ 2011-12-12T05:48:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-breckenridge-anda-for-methscopolamine-bromide-tablets-121211/ 2011-12-12T06:56:00+00:00 https://www.pharmaceutical-business-review.com/news/aeterna-zentaris-erk-12-inhibitor-yields-positive-data-in-breast-cancer-study-121211/ 2011-12-12T06:58:00+00:00 https://www.pharmaceutical-business-review.com/news/cenerx-completes-485m-financing-121211/ 2011-12-12T06:59:00+00:00 https://www.pharmaceutical-business-review.com/news/inkspot-science-develops-software-for-advancement-in-research-131211/ 2011-12-12T23:04:00+00:00 https://www.pharmaceutical-business-review.com/news/abbott-reata-partner-to-develop-oral-aims-131211/ 2011-12-12T23:38:00+00:00 https://www.pharmaceutical-business-review.com/news/ablynx-merck-advance-nanobody-candidate-into-pre-clinical-development-131211/ 2011-12-12T23:45:00+00:00 https://www.pharmaceutical-business-review.com/news/altogen-releases-sirna-liposome-encapsulation-technique-131211/ 2011-12-12T23:58:00+00:00 https://www.pharmaceutical-business-review.com/news/celladon-mydicar-drug-receives-fda-fast-track-status-131211/ 2011-12-13T01:06:00+00:00 https://www.pharmaceutical-business-review.com/news/immunomedics-veltuzumab-showed-efficacy-in-itp-131211/ 2011-12-13T01:11:00+00:00 https://www.pharmaceutical-business-review.com/news/immunomedics-develops-new-bispecific-antibodies-to-treat-tumors-131211/ 2011-12-13T01:17:00+00:00 https://www.pharmaceutical-business-review.com/news/receptos-strikes-research-and-development-deal-with-ono-131211/ 2011-12-13T01:57:00+00:00 https://www.pharmaceutical-business-review.com/news/symphogen-reports-positive-rozrolimupab-trial-results-131211/ 2011-12-13T03:03:00+00:00 https://www.pharmaceutical-business-review.com/news/neptune-announces-production-facility-expansion-131211/ 2011-12-13T04:37:00+00:00 https://www.pharmaceutical-business-review.com/news/plx3397-found-to-treat-acute-myeloid-leukemia-plexxikon-reports-131211/ 2011-12-13T04:40:00+00:00 https://www.pharmaceutical-business-review.com/news/health-canada-clears-feraheme-for-anemia-treatment-131211/ 2011-12-13T05:45:00+00:00 https://www.pharmaceutical-business-review.com/news/regulus-initiates-new-discovery-in-microrna-therapeutics-131211/ 2011-12-13T05:48:00+00:00 https://www.pharmaceutical-business-review.com/news/ec-grants-marketing-authorization-for-dificlir-to-treat-cdi-131211/ 2011-12-13T05:53:00+00:00 https://www.pharmaceutical-business-review.com/news/bioserve-fox-chase-cancer-center-expand-collaboration-131211/ 2011-12-13T06:17:00+00:00 https://www.pharmaceutical-business-review.com/news/enwave-merck-enter-research-evaluation-agreement-131211/ 2011-12-13T06:19:00+00:00 https://www.pharmaceutical-business-review.com/news/ucb-nordics-adopts-cegedim-mobile-intelligence-for-ipad-141211/ 2011-12-13T20:29:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-simcere-expand-collaboration-for-bms-795311-141211/ 2011-12-13T23:44:00+00:00 https://www.pharmaceutical-business-review.com/news/merrimack-commences-mm-121-study-in-cancer-patients-141211/ 2011-12-13T23:50:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-presents-inc424-phase-iii-study-results-141211/ 2011-12-14T00:00:00+00:00 https://www.pharmaceutical-business-review.com/news/marken-launches-new-logistics-operating-system-141211/ 2011-12-14T00:39:00+00:00 https://www.pharmaceutical-business-review.com/news/dsm-inks-manufacturing-supply-deal-with-qrxpharma-141211/ 2011-12-14T02:05:00+00:00 https://www.pharmaceutical-business-review.com/news/intellicell-signs-collaboration-deal-with-numoda-141211/ 2011-12-14T02:09:00+00:00 https://www.pharmaceutical-business-review.com/news/profectus-secures-54m-to-develop-treatment-for-virus-infections-141211/ 2011-12-14T03:03:00+00:00 https://www.pharmaceutical-business-review.com/news/tarsa-to-submit-nda-for-ostora-in-2012-141211/ 2011-12-14T03:11:00+00:00 https://www.pharmaceutical-business-review.com/news/liquidia-path-strike-deal-to-develop-pneumonia-vaccine-141211/ 2011-12-14T03:15:00+00:00 https://www.pharmaceutical-business-review.com/news/intarcia-quintiles-enter-deal-for-itca-650-development-141211/ 2011-12-14T03:19:00+00:00 https://www.pharmaceutical-business-review.com/news/cardium-introduces-medpodium-dietary-supplements-in-us-141211/ 2011-12-14T03:25:00+00:00 https://www.pharmaceutical-business-review.com/news/vanda-inks-fanapt-licensing-deal-with-megapharm-141211/ 2011-12-14T03:35:00+00:00 https://www.pharmaceutical-business-review.com/news/quintiles-introduces-cro-in-china-141211/ 2011-12-14T06:01:00+00:00 https://www.pharmaceutical-business-review.com/news/trophos-olesoxime-fails-to-yield-promising-data-141211/ 2011-12-14T06:15:00+00:00 https://www.pharmaceutical-business-review.com/news/china-botanic-develops-new-ginseng-polysaccharide-extract-powder-141211/ 2011-12-14T06:20:00+00:00 https://www.pharmaceutical-business-review.com/news/medeanalytics-releases-new-patient-access-intelligence-solution-151211/ 2011-12-14T19:19:00+00:00 https://www.pharmaceutical-business-review.com/news/biosante-presents-results-from-libigel-phase-iii-efficacy-trials-151211/ 2011-12-14T23:43:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-extends-research-collaboration-with-neurop-151211/ 2011-12-14T23:47:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-gives-notice-of-allowance-to-kythera-for-atx-101-patent-151211/ 2011-12-14T23:51:00+00:00 https://www.pharmaceutical-business-review.com/news/threshold-th-302-drug-found-to-treat-leukemia-151211/ 2011-12-15T00:36:00+00:00 https://www.pharmaceutical-business-review.com/news/adc-biotechnology-develops-cancer-drug-production-technology-151211/ 2011-12-15T00:43:00+00:00 https://www.pharmaceutical-business-review.com/news/us-researchers-develop-drug-delivery-technology-for-eye-diseases-151211/ 2011-12-15T00:56:00+00:00 https://www.pharmaceutical-business-review.com/news/kymos-strikes-rd-deal-with-ipsen-141211/ 2011-12-15T03:23:00+00:00 https://www.pharmaceutical-business-review.com/news/ge-healthcare-mw-group-sign-biopharmaceuticals-manufacturing-deal-151211/ 2011-12-15T03:31:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-viropharma-snda-for-modernized-labeling-of-vancocin-151211/ 2011-12-15T03:36:00+00:00 https://www.pharmaceutical-business-review.com/news/immunomedics-receives-us-patent-for-protein-therapeutic-manufacturing-151211/ 2011-12-15T03:41:00+00:00 https://www.pharmaceutical-business-review.com/news/nih-grants-1005m-to-sri-international-151211/ 2011-12-15T05:28:00+00:00 https://www.pharmaceutical-business-review.com/news/mmrf-onyx-enter-collaboration-for-multiple-myeloma-treatment-151211/ 2011-12-15T05:47:00+00:00 https://www.pharmaceutical-business-review.com/news/ahfd-manufactures-vitamin-fortified-energy-bars-151211/ 2011-12-15T05:59:00+00:00 https://www.pharmaceutical-business-review.com/news/true-healthy-products-introduces-new-whole-food-vitamin-supplement-151211/ 2011-12-15T06:08:00+00:00 https://www.pharmaceutical-business-review.com/news/salix-submits-nda-for-crofelemer-to-treat-hiv-associated-diarrhea-151211/ 2011-12-15T06:16:00+00:00 https://www.pharmaceutical-business-review.com/news/ccgroup-to-launch-cave-grouper-free-version-161211/ 2011-12-16T00:12:00+00:00 https://www.pharmaceutical-business-review.com/news/medshape-shape-memory-technology-wins-us-patent-161211/ 2011-12-16T00:16:00+00:00 https://www.pharmaceutical-business-review.com/news/gilenya-meets-phase-iii-study-endpoints-novartis-reports-161211/ 2011-12-16T00:21:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-phylogica-complete-first-phase-of-vaccine-development-deal-161211/ 2011-12-16T00:26:00+00:00 https://www.pharmaceutical-business-review.com/news/human-genome-sciences-gsk-commence-benlysta-trial-in-sle-patients-161211/ 2011-12-16T00:31:00+00:00 https://www.pharmaceutical-business-review.com/news/galapagos-receives-4m-milestone-payment-from-servier-161211/ 2011-12-16T00:35:00+00:00 https://www.pharmaceutical-business-review.com/news/vertex-kalydeco-gets-fda-nda-approval-161211/ 2011-12-16T02:18:00+00:00 https://www.pharmaceutical-business-review.com/news/enlight-joins-astrazeneca-novo-nordisk-for-therapeutics-development-161211/ 2011-12-16T02:26:00+00:00 https://www.pharmaceutical-business-review.com/news/morphosys-novozymes-enter-slonomics-technology-deal-161211/ 2011-12-16T03:49:00+00:00 https://www.pharmaceutical-business-review.com/news/lonza-to-expand-small-molecules-manufacturing-capacity-161211/ 2011-12-16T03:53:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-submits-snda-for-truvada-161211/ 2011-12-16T03:57:00+00:00 https://www.pharmaceutical-business-review.com/news/indian-firm-launches-protein-rich-products-161211/ 2011-12-16T05:48:00+00:00 https://www.pharmaceutical-business-review.com/news/soligenix-harvard-university-commence-anthrax-vaccine-development-261211/ 2011-12-16T06:19:00+00:00 https://www.pharmaceutical-business-review.com/news/cerulean-completes-15m-series-d-financing-161211/ 2011-12-16T06:21:00+00:00 https://www.pharmaceutical-business-review.com/news/enzymotec-wins-new-patent-for-omega-sterol-ingredient-161211/ 2011-12-16T06:26:00+00:00 https://www.pharmaceutical-business-review.com/news/healthesystems-introduces-new-state-reporting-tool-191211/ 2011-12-18T20:21:00+00:00 https://www.pharmaceutical-business-review.com/news/abgenomics-to-regain-abgn-168h-global-rights-from-boehringer-191211/ 2011-12-18T23:56:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-reports-positive-phase-3-study-results-of-lyrica-191211/ 2011-12-19T00:02:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-releases-metoprolol-succinate-extended-release-tablets-191211/ 2011-12-19T00:05:00+00:00 https://www.pharmaceutical-business-review.com/news/valeant-efinaconazole-yields-promising-data-in-onychomycosis-trials-191211/ 2011-12-19T00:10:00+00:00 https://www.pharmaceutical-business-review.com/news/thrombogenics-bioinvent-complete-patient-enrollment-for-tb-402phase-iib-trial-191211/ 2011-12-19T01:02:00+00:00 https://www.pharmaceutical-business-review.com/news/radius-completes-214m-third-financing-tranche-191211/ 2011-12-19T01:55:00+00:00 https://www.pharmaceutical-business-review.com/news/dsm-sinochem-to-set-up-ssc-production-plant-in-china-191211/ 2011-12-19T02:34:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-expands-pneumococcal-vaccine-supply-191211/ 2011-12-19T02:42:00+00:00 https://www.pharmaceutical-business-review.com/news/galapagos-glpg0778-meets-clinical-proof-of-mechanism-milestone-with-gsk-191211/ 2011-12-19T03:52:00+00:00 https://www.pharmaceutical-business-review.com/news/sygnature-and-cyprotex-extend-strategic-alliance-for-two-years-191211/ 2011-12-19T04:35:00+00:00 https://www.pharmaceutical-business-review.com/news/angel-signs-framework-agreement-with-transgenrx-191211/ 2011-12-19T04:39:00+00:00 https://www.pharmaceutical-business-review.com/news/summit-strikes-15m-deal-with-us-dmd-organizations-191211/ 2011-12-19T05:22:00+00:00 https://www.pharmaceutical-business-review.com/news/vernalis-h-lundbeck-reach-new-research-milestone-191211/ 2011-12-19T05:27:00+00:00 https://www.pharmaceutical-business-review.com/news/awareness-life-adds-new-weight-loss-product-to-range-191211/ 2011-12-19T05:31:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-sells-dermatology-business-to-valeant/ 2011-12-19T06:00:00+00:00 https://www.pharmaceutical-business-review.com/news/major-pharma-firms-deploy-perceptive-datalabs-edc-solution-201211/ 2011-12-19T18:34:00+00:00 https://www.pharmaceutical-business-review.com/news/galectin-reports-efficacy-data-of-gr-md-02-in-fatty-liver-disease-and-fibrosis-201211/ 2011-12-19T23:39:00+00:00 https://www.pharmaceutical-business-review.com/news/raptor-pharmaceutical-niddk-sign-rp104-development-deal-201211/ 2011-12-19T23:44:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-watson-to-develop-oncology-biosimilars-201211/ 2011-12-19T23:57:00+00:00 https://www.pharmaceutical-business-review.com/news/mjff-awards-research-grant-to-trevena-for-parkinsons-disease-201211/ 2011-12-20T00:09:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-recommends-approval-of-biomarin-production-plant-201211/ 2011-12-20T02:27:00+00:00 https://www.pharmaceutical-business-review.com/news/pacira-reports-phase-3-study-results-of-exparel-201211/ 2011-12-20T02:31:00+00:00 https://www.pharmaceutical-business-review.com/news/aviir-to-raise-30m-for-trurisk-201211/ 2011-12-20T02:34:00+00:00 https://www.pharmaceutical-business-review.com/news/impax-begins-ipx159-trial-in-restless-legs-syndrome-201211/ 2011-12-20T02:38:00+00:00 https://www.pharmaceutical-business-review.com/news/selexys-completes-selg1-trial-in-sickle-cell-disease-201211/ 2011-12-20T02:40:00+00:00 https://www.pharmaceutical-business-review.com/news/kinex-acquires-technology-and-products-rights-from-hanmi-201211/ 2011-12-20T02:46:00+00:00 https://www.pharmaceutical-business-review.com/news/yissum-launches-new-technology-for-anti-malaria-drug-production-201211/ 2011-12-20T05:57:00+00:00 https://www.pharmaceutical-business-review.com/news/agenus-chemrar-strike-cancer-vaccines-deal-201211/ 2011-12-20T06:01:00+00:00 https://www.pharmaceutical-business-review.com/news/alkermes-commences-alks-9070-trial-in-schizophrenia-treatment-201211/ 2011-12-20T06:05:00+00:00 https://www.pharmaceutical-business-review.com/news/pall-inks-deal-to-acquire-fortebio-201211/ 2011-12-20T06:10:00+00:00 https://www.pharmaceutical-business-review.com/news/vaxinnate-signs-licensing-contract-with-cj-cheiljedang-for-flu-vaccine-201211/ 2011-12-20T07:03:00+00:00 https://www.pharmaceutical-business-review.com/news/humc-receives-federal-reimbursement-for-use-of-health-it-system-211211/ 2011-12-20T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/zalicus-initiates-phase-1-trial-of-analgesic-drug-211211/ 2011-12-20T21:28:00+00:00 https://www.pharmaceutical-business-review.com/news/genzyme-tenere-study-yields-positive-data-in-ms-patients-211211/ 2011-12-20T22:44:00+00:00 https://www.pharmaceutical-business-review.com/news/chemdiv-signs-research-deal-with-janssen-and-tibotec-211211/ 2011-12-20T22:48:00+00:00 https://www.pharmaceutical-business-review.com/news/pulmatrix-isperse-drug-delivery-system-yields-positive-data-211211/ 2011-12-20T23:06:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-discontinues-rasilez-tekturna-trial-in-diabetic-patients-211211/ 2011-12-20T23:14:00+00:00 https://www.pharmaceutical-business-review.com/news/starpharma-lilly-drug-delivery-collaboration-progresses-211211/ 2011-12-20T23:21:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-nda-review-for-rheumatoid-arthritis-drug-211211/ 2011-12-20T23:29:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-edarbyclor-combination-therapy-gets-fda-clearance-211211/ 2011-12-21T00:23:00+00:00 https://www.pharmaceutical-business-review.com/news/antares-signs-licensing-contract-with-pfizer-consumer-healthcare-211211/ 2011-12-21T04:32:00+00:00 https://www.pharmaceutical-business-review.com/news/marshall-receives-us-patent-for-oncology-drug-compositions-211211/ 2011-12-21T04:35:00+00:00 https://www.pharmaceutical-business-review.com/news/proteotech-enters-into-drug-development-agreement-with-glaxosmithkline-211211/ 2011-12-21T04:57:00+00:00 https://www.pharmaceutical-business-review.com/news/hua-and-roche-sign-licensing-agreement-211211/ 2011-12-21T05:01:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-files-european-marketing-application-for-hiv-drug-211211/ 2011-12-21T05:17:00+00:00 https://www.pharmaceutical-business-review.com/news/ucb-initiates-exxelerate-rheumatoid-arthritis-study-211211/ 2011-12-21T05:24:00+00:00 https://www.pharmaceutical-business-review.com/news/galapagos-begins-phase-i-anti-inflammatory-drug-study-211211/ 2011-12-21T05:30:00+00:00 https://www.pharmaceutical-business-review.com/news/grunenthal-portugal-adopts-cegedim-mobile-intelligence-for-ipad-221211/ 2011-12-21T21:05:00+00:00 https://www.pharmaceutical-business-review.com/news/apeiron-gsk-begin-phase-iia-trial-in-acute-lung-injury-patients-221211/ 2011-12-22T00:27:00+00:00 https://www.pharmaceutical-business-review.com/news/marken-opens-new-pharmaceutical-service-depot-221211/ 2011-12-22T00:31:00+00:00 https://www.pharmaceutical-business-review.com/news/clinuvel-scenesse-yields-positive-data-in-epp-221211/ 2011-12-22T00:36:00+00:00 https://www.pharmaceutical-business-review.com/news/jennerex-reports-first-patient-treatment-in-jx-594-clinical-study-221211/ 2011-12-22T02:30:00+00:00 https://www.pharmaceutical-business-review.com/news/agilent-acquires-biosystem-development-business-221211/ 2011-12-22T02:33:00+00:00 https://www.pharmaceutical-business-review.com/news/purdue-awards-10m-to-transcept-for-intermezzo-listing-in-fda-orange-book-221211/ 2011-12-22T02:38:00+00:00 https://www.pharmaceutical-business-review.com/news/ontario-canada-helps-novocol-pharma-to-expand-cambridge-facility-221211/ 2011-12-22T03:10:00+00:00 https://www.pharmaceutical-business-review.com/news/xoma-initiates-phase-2-trial-of-gevokizumab-drug-221211/ 2011-12-22T03:33:00+00:00 https://www.pharmaceutical-business-review.com/news/anika-strikes-us-licensing-and-supply-deal-with-depuy-mitek-for-monovisc-221211/ 2011-12-22T03:37:00+00:00 https://www.pharmaceutical-business-review.com/news/radient-expands-distribution-agreement-with-unipharma-221211/ 2011-12-22T05:56:00+00:00 https://www.pharmaceutical-business-review.com/news/sla-pharma-completes-enrollment-for-diltiazem-phase-3-trial-221211/ 2011-12-22T06:01:00+00:00 https://www.pharmaceutical-business-review.com/news/lycera-reaches-milestone-in-research-collaboration-with-merck-221211/ 2011-12-22T06:06:00+00:00 https://www.pharmaceutical-business-review.com/news/prestige-to-buy-gsk-otc-brands-for-660m-221211/ 2011-12-22T06:12:00+00:00 https://www.pharmaceutical-business-review.com/news/dynavax-initiates-proof-of-mechanism-trial-for-sle-patients-221211/ 2011-12-22T07:46:00+00:00 https://www.pharmaceutical-business-review.com/news/amneal-releases-felbamate-oral-suspension-231211/ 2011-12-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/impax-submits-nda-parkinsons-disease-drug-231211/ 2011-12-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/dynavax-astrazeneca-to-advance-azd1419-study-231211/ 2011-12-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/cardium-sourceone-to-make-pharmaceutical-foods-nutritional-supplements-231211/ 2011-12-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/aveo-initiates-phase-2-colorectal-cancer-trial-231211/ 2011-12-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/covis-signs-licensing-deal-with-glaxosmithkline-231211/ 2011-12-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-gilead-nda-for-quad-hiv-regimen-261211/ 2011-12-25T23:46:00+00:00 https://www.pharmaceutical-business-review.com/news/thrombogenics-submits-ocriplasmin-bla-to-fda-261211/ 2011-12-25T23:51:00+00:00 https://www.pharmaceutical-business-review.com/news/veloxis-athena-enter-alliance-for-atorfen-drug-261211/ 2011-12-26T02:04:00+00:00 https://www.pharmaceutical-business-review.com/news/karo-bio-pfizer-strike-deal-for-autoimmune-diseases-drug-development-261211/ 2011-12-26T02:08:00+00:00 https://www.pharmaceutical-business-review.com/news/marina-biotech-mirna-therapeutics-to-develop-microrna-based-therapeutics-261211/ 2011-12-26T02:13:00+00:00 https://www.pharmaceutical-business-review.com/news/gg-introduces-two-new-multivitamin-products-for-women-261211/ 2011-12-26T02:17:00+00:00 https://www.pharmaceutical-business-review.com/news/epicept-gets-fda-nod-to-commence-amiket-clinical-development-261211/ 2011-12-26T03:16:00+00:00 https://www.pharmaceutical-business-review.com/news/tigenix-secures-funds-for-cx611-development-in-rheumatoid-arthritis-261211/ 2011-12-26T03:21:00+00:00 https://www.pharmaceutical-business-review.com/news/quidel-molecular-influenza-ab-assay-gets-fda-nod-261211/ 2011-12-26T05:28:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-quidel-molecular-hmpv-assay-261211/ 2011-12-26T05:35:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-receives-european-commission-approval-for-ovarian-cancer-therapy-261211/ 2011-12-26T06:26:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-resubmits-epilepsy-drug-nda-to-fda-271211/ 2011-12-27T00:03:00+00:00 https://www.pharmaceutical-business-review.com/news/sannova-requests-partial-change-in-neuzym-label-271211/ 2011-12-27T00:06:00+00:00 https://www.pharmaceutical-business-review.com/news/genscript-introduces-rush-gene-synthesis-service-271211/ 2011-12-27T01:24:00+00:00 https://www.pharmaceutical-business-review.com/news/igi-laboratories-strikes-deal-with-medimetriks-for-topical-drug-products-271211/ 2011-12-27T05:19:00+00:00 https://www.pharmaceutical-business-review.com/news/bdi-pharma-go-live-with-new-operating-system-281211/ 2011-12-27T19:43:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-perrigo-desloratadine-281211/ 2011-12-27T23:22:00+00:00 https://www.pharmaceutical-business-review.com/news/neuralstem-receives-fda-nod-to-advance-mdd-compound-to-phase-ib-ib-281211/ 2011-12-27T23:32:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-releases-eprosartan-mesylate-tablets-281211/ 2011-12-28T00:52:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-mylan-levetiracetam-extended-release-tablets-281211/ 2011-12-28T01:01:00+00:00 https://www.pharmaceutical-business-review.com/news/emergent-commences-tru-016-phase-2-study-in-leukemia-patients-291211/ 2011-12-29T00:42:00+00:00 https://www.pharmaceutical-business-review.com/news/immunomedics-ucb-revise-epratuzumab-deal-291211/ 2011-12-29T00:44:00+00:00 https://www.pharmaceutical-business-review.com/news/alnylam-reports-encouraging-pre-clinical-results-with-aln-htt-program-291211/ 2011-12-29T00:45:00+00:00 https://www.pharmaceutical-business-review.com/news/abbott-emergent-terminate-co-development-agreement-of-tru-016-291211/ 2011-12-29T03:55:00+00:00 https://www.pharmaceutical-business-review.com/news/owh-completes-enrollment-in-efficacy-study-of-kala-azar-treatment-in-bangladesh-291211/ 2011-12-29T03:57:00+00:00 https://www.pharmaceutical-business-review.com/news/united-therapeutics-remodulin-receives-french-regulatory-agency-approval-291211/ 2011-12-29T04:21:00+00:00 https://www.pharmaceutical-business-review.com/news/weedmaps-to-acquire-medical-marijuana-software-company-291011/ 2011-12-29T19:19:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-submits-snda-for-xarelto-301211/ 2011-12-30T01:03:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-extended-use-of-pfizer-prevnar-13-for-pneumonia-020112/ 2012-01-01T23:52:00+00:00 https://www.pharmaceutical-business-review.com/news/zealand-pharma-secures-eur-3m-in-elsiglutide-development-deal-020112/ 2012-01-01T23:56:00+00:00 https://www.pharmaceutical-business-review.com/news/zydus-cadila-plans-to-withdraw-from-drug-discovery-alliance-with-eli-lilly-020112/ 2012-01-02T01:20:00+00:00 https://www.pharmaceutical-business-review.com/news/proteonomix-completes-payment-for-umk-121-trial-for-end-stage-liver-disease-020112/ 2012-01-02T01:27:00+00:00 https://www.pharmaceutical-business-review.com/news/fuse-science-launches-enerjel-020112/ 2012-01-02T01:58:00+00:00 https://www.pharmaceutical-business-review.com/news/sinphar-strikes-drug-development-deal-with-macuclear-020112/ 2012-01-02T02:01:00+00:00 https://www.pharmaceutical-business-review.com/news/celator-raising-5m-for-cancer-drug-therapy-020112/ 2012-01-02T05:56:00+00:00 https://www.pharmaceutical-business-review.com/news/heat-biologics-plans-to-raise-41m-for-research-and-development-020112/ 2012-01-02T06:03:00+00:00 https://www.pharmaceutical-business-review.com/news/lyka-signs-pact-with-turkish-firm-020112/ 2012-01-02T06:08:00+00:00 https://www.pharmaceutical-business-review.com/news/ccs-emd-millipore-enter-licensing-deal-to-develop-cell-amounts-030112/ 2012-01-02T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/agile-completes-contraceptive-patch-trial-030112/ 2012-01-03T00:04:00+00:00 https://www.pharmaceutical-business-review.com/news/dalton-pharma-restructures-website-030112/ 2012-01-03T00:09:00+00:00 https://www.pharmaceutical-business-review.com/news/scripps-research-institute-appoints-michael-a-marletta-as-new-ceo-030112/ 2012-01-03T00:10:00+00:00 https://www.pharmaceutical-business-review.com/news/european-medical-center-deploys-critical-diagnostics-presage-st2-assay-030112/ 2012-01-03T00:14:00+00:00 https://www.pharmaceutical-business-review.com/news/echobase-adopts-gazzang-data-encryption-solution-for-new-mobile-interface-030112/ 2012-01-03T00:20:00+00:00 https://www.pharmaceutical-business-review.com/news/zirmed-amkaisolutions-to-provide-revenue-cycle-solutions-030112/ 2012-01-03T00:25:00+00:00 https://www.pharmaceutical-business-review.com/news/organic-health-labs-releases-new-anti-ageing-supplement-030112/ 2012-01-03T01:45:00+00:00 https://www.pharmaceutical-business-review.com/news/true-healthy-products-rolls-out-organic-wholefood-vitamin-c-030112/ 2012-01-03T02:08:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-to-appoint-jeremy-levin-as-new-ceo-030112/ 2012-01-03T03:45:00+00:00 https://www.pharmaceutical-business-review.com/news/julphar-to-commence-insulin-production-at-new-facility-030112/ 2012-01-03T05:41:00+00:00 https://www.pharmaceutical-business-review.com/news/mozambique-to-take-up-production-of-arvs-030112/ 2012-01-03T05:44:00+00:00 https://www.pharmaceutical-business-review.com/news/photocure-completes-patient-enrollment-in-cevira-study-030112/ 2012-01-03T05:48:00+00:00 https://www.pharmaceutical-business-review.com/news/apogenix-receives-additional-bmbf-grant-to-develop-apg101-030112/ 2012-01-03T06:29:00+00:00 https://www.pharmaceutical-business-review.com/news/lundbeck-announces-availability-of-anti-epileptic-drug-in-us-030112/ 2012-01-03T07:10:00+00:00 https://www.pharmaceutical-business-review.com/news/ossianix-to-generate-biopharmaceuticals-for-nervous-system-disorders-030112/ 2012-01-03T07:14:00+00:00 https://www.pharmaceutical-business-review.com/news/globalmed-joins-hp-to-release-mobile-telemedicine-carts-and-tablet-pc-040112/ 2012-01-03T19:05:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-grants-orphan-drug-status-to-novabiotics-lynovex-040112/ 2012-01-03T23:34:00+00:00 https://www.pharmaceutical-business-review.com/news/aveo-astellas-report-superiority-of-tivozanib-in-renal-cell-cancer-trial-040112/ 2012-01-03T23:47:00+00:00 https://www.pharmaceutical-business-review.com/news/quture-launches-cloud-application-on-the-intersystems-platform-040112/ 2012-01-04T00:22:00+00:00 https://www.pharmaceutical-business-review.com/news/accelrys-acquires-velquest-040112/ 2012-01-04T00:38:00+00:00 https://www.pharmaceutical-business-review.com/news/repros-completes-patient-dosing-in-phase-2-proellex-trial-040112/ 2012-01-04T00:51:00+00:00 https://www.pharmaceutical-business-review.com/news/goodwin-oncomax-strike-monoclonal-antibody-manufacturing-deal-040112/ 2012-01-04T03:32:00+00:00 https://www.pharmaceutical-business-review.com/news/orasure-submits-rapid-hiv-test-final-application-to-fda-040112/ 2012-01-04T03:41:00+00:00 https://www.pharmaceutical-business-review.com/news/isotechnika-vifor-pharma-enter-development-and-commercialization-license-deal-040112/ 2012-01-04T03:51:00+00:00 https://www.pharmaceutical-business-review.com/news/vernalis-genentech-enter-drug-discovery-deal-040112/ 2012-01-04T05:22:00+00:00 https://www.pharmaceutical-business-review.com/news/macuclear-secures-funds-to-advance-mc-1101-trial-040112/ 2012-01-04T05:32:00+00:00 https://www.pharmaceutical-business-review.com/news/alchemia-initiates-phase-iii-cancer-drug-study-040112/ 2012-01-04T05:39:00+00:00 https://www.pharmaceutical-business-review.com/news/bioinvent-and-servier-sign-oncology-research-collaboration-040112/ 2012-01-04T05:43:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-csl-behring-expanded-label-on-berinert-050112/ 2012-01-04T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/cms-assigns-j-code-for-eisai-halaven-injection-050112/ 2012-01-04T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/effik-spain-adopts-cegedim-mobile-intelligence-for-ipad-050112/ 2012-01-04T18:38:00+00:00 https://www.pharmaceutical-business-review.com/news/ironwood-bionomics-ink-research-and-license-agreement-050112/ 2012-01-04T23:46:00+00:00 https://www.pharmaceutical-business-review.com/news/celldex-commences-rindopepimut-combination-trial-050112/ 2012-01-04T23:51:00+00:00 https://www.pharmaceutical-business-review.com/news/ista-commences-phase-2-study-of-beposone-combination-nasal-spray-050112/ 2012-01-05T01:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-fast-track-status-to-achillion-ach-1625-drug-050112/ 2012-01-05T01:44:00+00:00 https://www.pharmaceutical-business-review.com/news/prana-secures-fda-nod-for-huntingtons-disease-trial-050112/ 2012-01-05T03:41:00+00:00 https://www.pharmaceutical-business-review.com/news/merz-pharmaceuticals-xeomin-receives-j-code-050112/ 2012-01-05T03:55:00+00:00 https://www.pharmaceutical-business-review.com/news/express-scripts-to-provide-services-for-regeneron-eylea-050112/ 2012-01-05T04:00:00+00:00 https://www.pharmaceutical-business-review.com/news/abbott-funds-neurogenetic-alzheimers-disease-research-050112/ 2012-01-05T04:11:00+00:00 https://www.pharmaceutical-business-review.com/news/aaipharma-acquires-celsis-analytical-services-050112/ 2012-01-05T04:48:00+00:00 https://www.pharmaceutical-business-review.com/news/biogen-idec-isis-form-alliance-for-smadrug-development-050112/ 2012-01-05T04:56:00+00:00 https://www.pharmaceutical-business-review.com/news/oncodesign-ipsen-partner-to-develop-parkinsons-disease-therapeutic-agents-050112/ 2012-01-05T06:33:00+00:00 https://www.pharmaceutical-business-review.com/news/octoplus-announces-drug-delivery-contract-expansion-050112/ 2012-01-05T06:38:00+00:00 https://www.pharmaceutical-business-review.com/news/lannett-fda-reach-spa-agreement-for-cocaine-hcl-trial-050112/ 2012-01-05T06:42:00+00:00 https://www.pharmaceutical-business-review.com/news/kedem-enters-contract-with-corealis-pharma-for-kdm-1102-supplies-050112/ 2012-01-05T06:48:00+00:00 https://www.pharmaceutical-business-review.com/news/hangzhou-awards-research-and-development-grant-to-ascletis-050112/ 2012-01-05T06:55:00+00:00 https://www.pharmaceutical-business-review.com/news/mckesson-announces-first-cloud-based-supply-chain-solution-060112/ 2012-01-05T19:15:00+00:00 https://www.pharmaceutical-business-review.com/news/bt-extends-managed-services-contract-with-bristol-myers-squibb-060112/ 2012-01-05T21:52:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-to-advance-targacept-alzheimers-drug-060112/ 2012-01-05T23:58:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-commences-catalyst-biosciences-hemophilia-drug-trial-060112/ 2012-01-06T00:11:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-to-further-develop-chemocentryx-ccr1-inhibitor-for-rheumatoid-arthritis-060112/ 2012-01-06T00:19:00+00:00 https://www.pharmaceutical-business-review.com/news/ensemble-bristol-myers-squibb-extend-collaboration-060112/ 2012-01-06T00:31:00+00:00 https://www.pharmaceutical-business-review.com/news/lasya-releases-new-cosmetic-cream-060112/ 2012-01-06T00:39:00+00:00 https://www.pharmaceutical-business-review.com/news/baxter-commences-phase-1-study-of-bax-855-060112/ 2012-01-06T02:16:00+00:00 https://www.pharmaceutical-business-review.com/news/vitamin-shoppe-launches-new-line-of-sports-nutrition-products-060112/ 2012-01-06T02:23:00+00:00 https://www.pharmaceutical-business-review.com/news/eyegate-begins-patient-enrollment-in-anterior-uveitis-study-060112/ 2012-01-06T03:00:00+00:00 https://www.pharmaceutical-business-review.com/news/natural-medical-supply-launches-liquid-protein-supplement-060112/ 2012-01-06T03:09:00+00:00 https://www.pharmaceutical-business-review.com/news/tetragenetics-announces-positive-results-from-h5n1-influenza-vaccine-study-060112/ 2012-01-06T03:14:00+00:00 https://www.pharmaceutical-business-review.com/news/forma-boehringer-enter-oncology-drugs-development-alliance-060112/ 2012-01-06T03:28:00+00:00 https://www.pharmaceutical-business-review.com/news/monosol-midatech-launch-new-strategic-joint-venture-060112/ 2012-01-06T05:04:00+00:00 https://www.pharmaceutical-business-review.com/news/toray-to-acquire-stake-in-mbj-060112/ 2012-01-06T05:08:00+00:00 https://www.pharmaceutical-business-review.com/news/rt-oncology-services-metro-medical-supply-enter-distribution-deal-060112/ 2012-01-06T05:20:00+00:00 https://www.pharmaceutical-business-review.com/news/syndax-ventana-to-devise-companion-diagnostic-test-for-entinostat-060112/ 2012-01-06T05:26:00+00:00 https://www.pharmaceutical-business-review.com/news/cmc-biologics-secures-european-patent-for-biomanufacturing-technology-060112/ 2012-01-06T05:41:00+00:00 https://www.pharmaceutical-business-review.com/news/zygem-usamriid-sign-deal-for-biothreat-agents-solutions-060112/ 2012-01-06T05:46:00+00:00 https://www.pharmaceutical-business-review.com/news/bonavitas-releases-new-natural-energy-drink-060112/ 2012-01-06T05:49:00+00:00 https://www.pharmaceutical-business-review.com/news/galena-receives-fda-approval-for-phase-2-trial-for-neuvax-with-herceptin-060112/ 2012-01-06T06:57:00+00:00 https://www.pharmaceutical-business-review.com/news/aegerion-lomitapide-drug-found-to-treat-hypercholesterolemia-090112/ 2012-01-08T23:51:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-terminates-vibativ-for-injection-agreement-with-theravance-090112/ 2012-01-08T23:56:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-consumer-health-recalls-certain-over-the-counter-products-090112/ 2012-01-09T00:40:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-signs-deal-to-buy-inhibitex-090112/ 2012-01-09T00:43:00+00:00 https://www.pharmaceutical-business-review.com/news/bcx4208-combination-therapy-shows-efficacy-against-gout-biocryst-reports-090112/ 2012-01-09T01:50:00+00:00 https://www.pharmaceutical-business-review.com/news/circadian-initiates-vgx-100-trial-in-cancer-patients-090112/ 2012-01-09T01:55:00+00:00 https://www.pharmaceutical-business-review.com/news/india-to-inspect-chinese-drug-manufacturing-firms-090112/ 2012-01-09T02:01:00+00:00 https://www.pharmaceutical-business-review.com/news/strides-arcolab-to-sell-australian-unit-090112/ 2012-01-09T02:08:00+00:00 https://www.pharmaceutical-business-review.com/news/qiagen-releases-new-sample-preparation-automation-system-090112/ 2012-01-09T03:08:00+00:00 https://www.pharmaceutical-business-review.com/news/south-korea-approves-anti-leukemia-drug-production-090112/ 2012-01-09T03:16:00+00:00 https://www.pharmaceutical-business-review.com/news/qiagen-mpiib-to-develop-tb-risk-assessment-assay-090112/ 2012-01-09T03:23:00+00:00 https://www.pharmaceutical-business-review.com/news/endo-biodelivery-ink-bema-buprenorphine-deal-090112/ 2012-01-09T04:57:00+00:00 https://www.pharmaceutical-business-review.com/news/civitas-cvt-301-trial-yields-positive-data-in-parkinsons-disease-090112/ 2012-01-09T05:02:00+00:00 https://www.pharmaceutical-business-review.com/news/shire-icon-sign-new-strategic-partnership-090112/ 2012-01-09T06:00:00+00:00 https://www.pharmaceutical-business-review.com/news/silence-miragen-to-evaluate-dbtc-delivery-system-090112/ 2012-01-09T06:05:00+00:00 https://www.pharmaceutical-business-review.com/news/blend-therapeutics-to-develop-integrative-combination-medicines-090112/ 2012-01-09T06:14:00+00:00 https://www.pharmaceutical-business-review.com/news/reckitt-benckiser-chooses-cegedim-solutions-100112/ 2012-01-09T19:49:00+00:00 https://www.pharmaceutical-business-review.com/news/sfj-pharma-pfizer-ink-axitinib-development-deal-for-rcc-treatment-100112/ 2012-01-09T23:53:00+00:00 https://www.pharmaceutical-business-review.com/news/biodesix-secures-eu-us-patents-for-oncology-tests-100112/ 2012-01-09T23:59:00+00:00 https://www.pharmaceutical-business-review.com/news/molecularhealth-to-launch-drug-safety-solutions-100112/ 2012-01-10T00:19:00+00:00 https://www.pharmaceutical-business-review.com/news/tron-adopts-ingenuity-variant-analysis-software-100112/ 2012-01-10T00:24:00+00:00 https://www.pharmaceutical-business-review.com/news/lexicon-reports-positive-results-of-lx4211-combination-therapy-100112/ 2012-01-10T00:46:00+00:00 https://www.pharmaceutical-business-review.com/news/sigma-aldrich-to-buy-bioreliance-100112/ 2012-01-10T01:27:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-theravance-report-completion-of-relovair-studies-in-copd-and-asthma-100112/ 2012-01-10T01:31:00+00:00 https://www.pharmaceutical-business-review.com/news/ashland-plans-to-expand-polyplasdone-polyclar-production-100112/ 2012-01-10T03:21:00+00:00 https://www.pharmaceutical-business-review.com/news/idx184-drug-shows-efficacy-against-hcv-idenix-reports-100112/ 2012-01-10T03:29:00+00:00 https://www.pharmaceutical-business-review.com/news/apricus-abbott-strike-deal-to-commercialize-vitaros-in-canada-100112/ 2012-01-10T03:34:00+00:00 https://www.pharmaceutical-business-review.com/news/omthera-announces-positive-bioavailability-data-from-epanova-study-100112/ 2012-01-10T05:57:00+00:00 https://www.pharmaceutical-business-review.com/news/xenon-genentech-enter-alliance-to-discover-pain-therapeutics-100112/ 2012-01-10T06:01:00+00:00 https://www.pharmaceutical-business-review.com/news/hospira-initiates-phase-iii-biosimilar-erythropoietin-study-100112/ 2012-01-10T06:06:00+00:00 https://www.pharmaceutical-business-review.com/news/baxter-submits-gammagard-liquid-sbla-to-fda-100112/ 2012-01-10T06:09:00+00:00 https://www.pharmaceutical-business-review.com/news/micromet-nci-enter-crada-to-advance-blinatumomab-development-100112/ 2012-01-10T06:13:00+00:00 https://www.pharmaceutical-business-review.com/news/bioderma-spain-deploys-cegedim-crm-tool-110112/ 2012-01-10T19:36:00+00:00 https://www.pharmaceutical-business-review.com/news/us-medical-center-installs-thomson-reuters-medication-management-solution-110112/ 2012-01-10T23:28:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmos-initiates-gout-drug-proof-of-concept-trial-110112/ 2012-01-10T23:42:00+00:00 https://www.pharmaceutical-business-review.com/news/forma-therapeutics-janssen-biotech-ink-drug-discovery-agreement-110112/ 2012-01-10T23:47:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-ucsf-in-diabetes-research-collaboration-110112/ 2012-01-11T01:08:00+00:00 https://www.pharmaceutical-business-review.com/news/ablynx-earns-extended-gmp-certificate-for-new-gmp-facility-110112/ 2012-01-11T01:14:00+00:00 https://www.pharmaceutical-business-review.com/news/cubist-hydra-biosciences-to-commence-pain-drug-trial-110112/ 2012-01-11T01:48:00+00:00 https://www.pharmaceutical-business-review.com/news/trophogen-abl-sign-rhfsh-analog-contract-manufacturing-deal-110112/ 2012-01-11T01:54:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-arena-nda-for-lorcaserin-110112/ 2012-01-11T03:02:00+00:00 https://www.pharmaceutical-business-review.com/news/medgenesis-raises-5m-to-support-parkinsons-drug-development-110112/ 2012-01-11T03:06:00+00:00 https://www.pharmaceutical-business-review.com/news/epizyme-secures-4m-milestone-payment-from-eisai-110112/ 2012-01-11T04:51:00+00:00 https://www.pharmaceutical-business-review.com/news/shire-signs-licensing-contract-with-janssen-for-resolor-110112/ 2012-01-11T04:52:00+00:00 https://www.pharmaceutical-business-review.com/news/ventana-collaborates-with-pfizer-cst-for-lung-cancer-diagnosis-110112/ 2012-01-11T05:01:00+00:00 https://www.pharmaceutical-business-review.com/news/nantworks-to-establish-855m-manufacturing-facilty-110112/ 2012-01-11T05:07:00+00:00 https://www.pharmaceutical-business-review.com/news/chromadex-launches-new-line-of-dietary-supplements-in-us-110112/ 2012-01-11T05:13:00+00:00 https://www.pharmaceutical-business-review.com/news/biotechnology-firm-adopts-newcardio-qtinno-120112/ 2012-01-11T21:08:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-receives-morrison-foerster-advice-on-camurus-deal-120112/ 2012-01-11T23:36:00+00:00 https://www.pharmaceutical-business-review.com/news/merrimack-doses-first-patient-in-mm-151-trial-120112/ 2012-01-11T23:40:00+00:00 https://www.pharmaceutical-business-review.com/news/kadmon-enters-agreement-with-chiromics-for-chemical-compounds-library-120112/ 2012-01-11T23:50:00+00:00 https://www.pharmaceutical-business-review.com/news/perkinelmer-to-release-new-image-data-storage-and-analysis-system-120112/ 2012-01-12T00:08:00+00:00 https://www.pharmaceutical-business-review.com/news/oramed-files-us-patent-application-for-diabetes-treatment-120112/ 2012-01-12T01:37:00+00:00 https://www.pharmaceutical-business-review.com/news/octoplus-to-develop-new-controlled-release-formulation-120112/ 2012-01-12T01:40:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-nda-extension-for-hemispherx-cfs-therapeutic-120112/ 2012-01-12T01:43:00+00:00 https://www.pharmaceutical-business-review.com/news/amerigen-fosun-omni-to-develop-generic-oral-controlled-release-products-120112/ 2012-01-12T01:46:00+00:00 https://www.pharmaceutical-business-review.com/news/polaris-initiates-phase-i-prostate-cancer-trial-120112/ 2012-01-12T01:49:00+00:00 https://www.pharmaceutical-business-review.com/news/amerigen-viwa-enter-jv-to-manufacture-sell-branded-generic-drugs-in-china-120112/ 2012-01-12T02:33:00+00:00 https://www.pharmaceutical-business-review.com/news/clydesdale-bank-funds-sep-120112/ 2012-01-12T03:11:00+00:00 https://www.pharmaceutical-business-review.com/news/merrimack-initiates-human-clinical-trial-of-adimab-antibodies-120112/ 2012-01-12T03:14:00+00:00 https://www.pharmaceutical-business-review.com/news/microtest-to-manufacture-immusant-immunotherapeutic-vaccine-120112/ 2012-01-12T03:29:00+00:00 https://www.pharmaceutical-business-review.com/news/quick-med-receives-us-patent-for-nimbus-antimicrobial-technology-120112/ 2012-01-12T05:32:00+00:00 https://www.pharmaceutical-business-review.com/news/evotec-receives-fourth-milestone-payment-from-boehringer-120112/ 2012-01-12T05:35:00+00:00 https://www.pharmaceutical-business-review.com/news/china-nuokang-acquires-alpha-lipoic-acid-capsule-for-diabetic-patients-120112/ 2012-01-12T07:32:00+00:00 https://www.pharmaceutical-business-review.com/news/intellicell-regenastem-enter-svf-manufacturing-technology-deal-120112/ 2012-01-12T07:41:00+00:00 https://www.pharmaceutical-business-review.com/news/purx-health-launches-immune-system-boosting-supplements-120112/ 2012-01-12T07:45:00+00:00 https://www.pharmaceutical-business-review.com/news/novella-upgrades-pharmacovigilance-services-130112/ 2012-01-12T20:14:00+00:00 https://www.pharmaceutical-business-review.com/news/aerocrine-secures-south-korean-taiwanese-market-approvals-for-niox-mino-130112/ 2012-01-12T23:54:00+00:00 https://www.pharmaceutical-business-review.com/news/kedem-begins-anti-cancer-drug-development-130112/ 2012-01-12T23:57:00+00:00 https://www.pharmaceutical-business-review.com/news/csl-behring-commences-rix-fp-trial-in-hemophilia-patients-130112/ 2012-01-13T00:01:00+00:00 https://www.pharmaceutical-business-review.com/news/novalix-signs-drug-discovery-deal-with-teijin-pharma-130112/ 2012-01-13T00:04:00+00:00 https://www.pharmaceutical-business-review.com/news/fei-nih-enter-structural-biology-research-deal-130112/ 2012-01-13T01:35:00+00:00 https://www.pharmaceutical-business-review.com/news/chesapeake-installs-new-vijuk-mv-2011-folder-130112/ 2012-01-13T01:38:00+00:00 https://www.pharmaceutical-business-review.com/news/islet-sciences-chooses-neostem-unit-for-product-manufacturing-130112/ 2012-01-13T01:42:00+00:00 https://www.pharmaceutical-business-review.com/news/prasco-releases-authorized-generic-shire-drug-130112/ 2012-01-13T01:53:00+00:00 https://www.pharmaceutical-business-review.com/news/biovest-max-planck-institute-ink-viral-vaccine-manufacturing-deal-130112/ 2012-01-13T04:51:00+00:00 https://www.pharmaceutical-business-review.com/news/general-dynamics-wins-navy-medicine-research-contract-130112/ 2012-01-13T04:57:00+00:00 https://www.pharmaceutical-business-review.com/news/vitalmax-vitamins-adds-omega-3-krill-oil-supplement-to-its-product-portfolio-130112/ 2012-01-13T05:01:00+00:00 https://www.pharmaceutical-business-review.com/news/sobi-o4cp-enter-bumetanide-licensing-deal-130112/ 2012-01-13T06:19:00+00:00 https://www.pharmaceutical-business-review.com/news/omni-bio-to-commence-type-1-diabetes-gvhd-trials-160112/ 2012-01-15T23:53:00+00:00 https://www.pharmaceutical-business-review.com/news/viropharma-receives-priority-review-status-for-cinryze-in-canada-160112/ 2012-01-15T23:56:00+00:00 https://www.pharmaceutical-business-review.com/news/ventrus-reports-iferanserin-phase-2b-trial-data-160112/ 2012-01-16T01:46:00+00:00 https://www.pharmaceutical-business-review.com/news/lundbeck-launches-sycrest-in-uk-160112/ 2012-01-16T03:09:00+00:00 https://www.pharmaceutical-business-review.com/news/nuron-licenses-hibtiter-vaccine-to-mitsubishi-160112/ 2012-01-16T03:12:00+00:00 https://www.pharmaceutical-business-review.com/news/otsuka-seeks-japanese-approval-for-dopamine-agonist-transdermal-patch-160112/ 2012-01-16T04:26:00+00:00 https://www.pharmaceutical-business-review.com/news/ucb-otsuka-to-focus-on-therapeutic-area-of-cns-disorders-160112/ 2012-01-16T04:32:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-to-restructure-us-business-160112/ 2012-01-16T04:35:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-nobelpharma-to-launch-anticonvulsant-agent-160112/ 2012-01-16T05:59:00+00:00 https://www.pharmaceutical-business-review.com/news/pergamum-initiates-phase-ii-study-of-dpk060-160112/ 2012-01-16T06:00:00+00:00 https://www.pharmaceutical-business-review.com/news/medicinova-university-of-colorado-boulder-enter-into-licensing-agreement-160112/ 2012-01-16T07:37:00+00:00